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Introduction 
The Cyanotoxins Workgroup was charged with the identification and pri-
oritization of research needs associated with: the identification of cyano-
toxins; toxicokinetics and toxicodynamics of cyanotoxins; human suscep-
tibility to the toxins; cyanobacterial genetics/omics and factors for inclu-
sion in predictive models of toxin production; and risk reduction from an 
intentional or accidental release of cyanotoxins.  Papers presented for the 
Cyanotoxins Session of the symposium on toxin types, toxicokinetics, and 
toxicodyamics (See Humpage this volume), cyanobacterial genetics of 
toxin production (See Neilan this volume), and parameters related to hu-
man risks from cyanobacterial exposure (See Love this volume) set the 
stage for Cyanotoxins Workgroup discussions. 
A consensus was achieved regarding the need to focus on the major 
identified classes of cyanotoxins. The group expressed the belief that the 
most significant toxic components of presently occurring harmful algal 
blooms have been identified, and the knowledge gaps for these most 
prevalent toxins are great enough to warrant the attention of most of our 
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future research. This belief does not negate the need to study mixtures of 
cyanotoxins and toxin precursors, especially those most likely to occur 
within a given bloom.  Moreover, there is also a significant likelihood that 
novel cyanobacterial blooms and toxins will continue to emerge, and fu-
ture identification of unknown bloom-forming species and their toxins will 
require ongoing diligence. 
Charge 1: Identification 
Identify and prioritize research needs concerning the identification 
and quantification of cyanobacteria, cyanotoxins, and their toxici-
ties. 
 
The public health, environmental health, and economic impacts resulting 
from harmful algal blooms (HABs) create the need to prioritize research 
for the detection and identification of cyanotoxins.  To comply with the 
Safe Drinking Water Act (SDWA), the U.S. EPA must identify contami-
nants that may require regulation in the future and periodically publish the 
resulting Contaminant Candidate List (CCL).  The EPA identifies the data 
gaps associated with the contaminants on the CCL to prioritize research 
and data compilation to determine whether regulation of candidate con-
taminants is warranted.   
In 1998 and again in 2005, EPA listed “Cyanobacteria (blue-green al-
gae), other freshwater algae, and their toxins” on the CCL.  The Work-
group felt that the CCL should be more specific; for example, listing the 
individual cyanobacteria and toxins of concern.  Many genera and species 
of cyanobacteria are non-toxic; however, many other genera and species 
can produce a single known toxin and, conversely, a single species can 
produce a range of cyanotoxins.  More detailed listings may evolve be-
cause the CCL is an iterative process that assimilates new data on con-
taminants as well as recommendations from authorized workgroups.  More 
information can be obtained on the EPA CCL website, 
http://www.epa.gov/safewater/ccl/index.html. 
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Research Priority:  Protocols for efficient production, 
certification, and distribution of pure toxins and standards of 
consistent, high quality. 
Rapid and sensitive detection of cyanotoxins is an important goal for miti-
gating potential risks posed by HABs.  Sensitivity and specificity of ana-
lytical methods for identifying the different classes of cyanotoxins and for 
accurate quantification depend on the availability of high quality toxin 
standards.  The workgroup expressed concern that some published re-
search was not as reliable as it might be because of reliance on in-house 
purification of toxins or use of commercial material that was later shown 
to be of poor quality.  Standardized protocols are needed for the efficient 
production, certification, and distribution of pure toxins and standards.  
Commercial standards for cylindrospermopsin, some microcystins, nodu-
larin, anatoxin-a, and saxitoxins are available (Table 1). However, concern 
regarding the reliability of some of the non-certified commercial standards 
has been expressed. Larger (mg) quantities of some cyanotoxins are avail-
able from certain research labs involved in cyanobacterial research, for ex-
ample, the Australian Water Quality Centre (http://www.awqc.com.au/).  
Another concern is that recent regulations of high potency agents and tox-
ins hamper the acquisition and storage of large toxin quantities that are 
needed for analytical methods development, validation, and, toxicological 
studies.  Although safeguards are needed to prevent illicit uses of cyano-
toxins, provisions for safe transportation and use in secure facilities are 
needed.
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This issue has also been addressed by other international organizations. 
A technical report available from the Organisation for the Prohibition of 
Chemical Weapons (OPCW) website (http://www.opcw.org/html/global-
/s_series/98/s78_98.html) indicates that international access to tritiated 
saxitoxin is extremely limited, and that most nations do not have access to 
expensive HPLC systems for monitoring saxitoxin levels.  Increased avail-
ability and distribution of standards, in addition to inexpensive monitoring 
and detection systems, are urgently needed to monitor cyanobacterial tox-
ins. The UN Food and Agriculture Organization (FAO) also addressed this 
issue.  “It is possible to measure PSP [paralytic shellfish poisoning] com-
pounds by a number of analytical-chemical methods but they all have 
some limitations, and they often cannot easily be operated because of the 
lack of reference materials, although recently some progress has been 
made in this area. However, they are expensive and mainly available from 
one source. The efforts undertaken by the European Commission’s SMT 
Programme have led to shellfish reference materials with certified mass 
fractions of some of the toxicologically most significant PSP toxins. De-
spite these positive developments, the analytical situation remains difficult 
and the lack of pure PSP compounds in sufficient quantities for repeated 
dose toxicity studies is a limiting factor in the development of reliable risk 
assessment.” (Marine Biotoxins, FAO Food and Nutrition Paper Number 
80, 2004). The recent Harmful Algal Research and Response plan 
(HARRNESS 2005) also listed establishment of reference material infra-
structure and improved availability and distribution of toxins and their me-
tabolites as top priorities.  
The workgroup concluded that reliable, well-characterized standards are 
needed for as many of the common toxins and congeners as possible so 
that research results from different laboratories can be reconciled.  The 
lack of pure toxins and standards not only limits monitoring efforts, but the 
ability of investigators to conduct the chronic, low-dose toxicity studies 
required for risk assessment.  Currently it is inadvisable to have detailed 
protocols for the production of cyanotoxins widely distributed, as these 
could be used as recipes by bioterrorists.  One option for safely acquiring 
adequate quantities of standards for research is to designate a few reputa-
ble and qualified laboratories as infrastructure resources for producing, 
certifying, and distributing specific chemical groups on an “at-cost” basis.  
These services must be provided at a cost that is not prohibitive of their 
use.  In-house production by individual investigators was not the preferred 
option due to the resource and economic drain that would impede research 
efforts, and because of the lack of ability to fully characterize the material 
produced.  
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Standards for four groups of toxins were designated high priority: mi-
crocystins, cylindrospermopsins, anatoxin-a, and saxitoxins (i.e., PSPs).  
All four toxin groups are relevant to the U.S. EPA because they are highly 
distributed in the U.S.  All four groups can impact drinking water reser-
voirs, farm irrigation, and recreational activities in freshwater environ-
ments. 
Dangerous Goods Regulations and the Transport of Cyanotoxins 
Cyanotoxins come under Dangerous Goods (DG) regulations for transport 
of hazardous materials (Metcalf et al. 2006).  These regulations are defined 
under UN and IATA frameworks, but many countries have their own spe-
cific regulations as well, particularly for control of import and export. By 
law, such materials must be packed for transport by people specially 
trained and licensed for DG handling to ensure compliance with DG trans-
port regulations. Freight companies will not accept these materials unless a 
licensed DG handler certifies that the package and labeling comply with 
the regulations. Material Safety Data Sheets specific to the DG must ac-
company the package. Only a few freight agents routinely transport DGs 
around the world. Most of them employ Custom’s Brokers to facilitate im-
portation into the destination country. It is important to use one of these 
companies to avoid delays, despite the added cost. It is also important to 
obtain legal opinion to ensure compliance with the plethora of DG and 
other relevant regulations, particularly for saxitoxins and microcystins be-
cause of the added Chemical Weapons Convention (CWC) regulations that 
apply to these toxins. Australia’s CWC regulations require an export per-
mit and quarterly reports on toxin use from the recipient. Although signifi-
cant effort is required to develop this capability, it is no longer acceptable 
to simply mail “research materials” without taking DG and other regula-
tions into account. These requirements will limit the number of labs that 
find it worthwhile to produce and supply cyanotoxins, again pointing to 
the need for infrastructure resources for production, certification, and dis-
tribution. 
Developing Standard Methods to Separate and Identify Toxic 
Components of Raw Water and Crude Extracts  
Prior to identifying research needs concerning the development of analyti-
cal methods to identify cyanotoxins, the workgroup recognized several 
overarching considerations and discussed current methods development 
projects.  Methods are needed to identify the cyanobacterial species that 
comprise a bloom, as well as to identify individual cyanotoxins within the 
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bloom.  Additionally, it is important to develop methods that discriminate 
between cyanobacterial strains and species that are capable and incapable 
of producing cyanotoxins that may pose risks in both recreational and 
drinking waters.  
  Microscopy or morphology-based monitoring is the method traditionally 
used to identify potentially toxigenic cyanobacteria.  A monitoring or 
screening process has been instituted in Australia to monitor sources of 
drinking water, whereby the presence and quantity of cyanobacterial cells 
are identified based on microscopic observations of water samples.  When 
cyanobacteria are present in significant numbers (“Alert Levels”), addi-
tional biochemical and molecular assays further characterize the cyanobac-
teria present.  If toxicity screening assays are positive, additional treatment 
processes are included to mitigate the likelihood of toxins persisting 
through to the finished water.  This approach relies on cellular morphology 
to identify species that can potentially produce toxins; however, this me-
thod does not determine whether a particular toxin is, in fact, present. 
Standard methods exist for the separation and identification of many 
cyanobacterial toxins (for examples, see Meriluoto and Codd 2005, Moore 
1996, WHO 1999 [http://www.who.int/docstore/water_sanitation_health-
/toxicyanobact/]).  However, there is continuing need to develop assays for 
newly discovered toxins, for methods refinement, and for validation and 
certification by organizations such as the AOAC International, a non-profit 
association of analytical communities.  A current project is refining exist-
ing methods and developing new methods to support the collection of 
cyanotoxin occurrence data in cells and surface water. The project, entitled 
“Determination and Significance of Emerging Algal Toxins (Cyanotox-
ins),” is sponsored by the American Water Works Research Foundation 
(AwwaRF Project 2789, http://www.awwarf.org/research/TopicsAnd-
Projects/projectSnapshot.aspx?pn=2789). 
As better analytical methods have been developed in the shellfish indus-
try (for example more sophisticated mass spectrometry), more toxin ana-
logs have been detected.  However, since toxicological data are unavail-
able for these compounds, regulators cannot use an evidence-based ap-
proach for toxicity classification.  It is therefore important that toxico-
logical characterization keeps pace with detection of new compounds.  An 
alternative approach is further development of a structure-activity classifi-
cation system. Less satisfactory is use of the default assumption that toxic-
ity of an analog is equivalent to that of the most toxic known congener. 
 
Emerging and novel cyanobacteria and their toxins.  The workgroup con-
sidered the need for field ready, reliable, and inexpensive methods to de-
tect currently known, common cyanobacteria and their toxins to be a 
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higher priority research need than the identification of novel cyanobacteria 
and cyanotoxins.  The workgroup agreed that the major cyanotoxins which 
pose health and ecological risks have been identified. Emerging toxins 
were considered of somewhat lesser importance than the need for im-
proved methods to assess known organisms and toxins.  Historically, new 
toxins have been found due to accidental poisoning of wild, farm or do-
mestic animals (or in the case of cylindrospermopsin, humans), rather than 
through formal surveys.  Better links with veterinarians and National Parks 
staff, for example, would facilitate this process.   
 
Complex mixtures.  The identification and prioritization of research needs 
concerning cyanotoxin identification and quantification represents a 
unique challenge because cyanobacterial toxins generally occur as mix-
tures. The toxins usually occur as mixtures of analogs of the same toxin 
type (for example, there are about eighty known microcystins) and/or mix-
tures of different toxin types (for example, microcystins mixed with cylin-
drospermopsin.  Toxicity screening assays are required to determine the to-
tal toxicity of mixtures present in blooms because all mixture components 
are not likely to be identified in toxin identification assays. 
 
Synergisms in complex mixtures.  Another aspect of the “known toxin” 
and “new toxin” issue is the observation that toxicity assessments of crude 
cell extracts usually indicate greater toxicity than can be attributed to the 
known toxins within the mixture.  Similar patterns appear in many studies 
of chemical ecology (Paul et al. 2001, Pietsch et al. 2001).  Although in 
some cases this situation can be taken as evidence of undiscovered toxins, 
the possibility has also been raised that there are compounds produced by 
cyanobacteria that, although not toxic themselves, can modify the effect of 
the known toxins.  These could be non-toxic analogs of known toxins.  
This issue has received little research attention thus far.  Furthermore, the 
list of non-toxic but biologically active compounds known to be produced 
by cyanobacteria is continually growing (see Table 1 in Humpage this vol-
ume).  
Because compounds present in minor concentrations may have additive 
or synergistic effects with the pure toxins of interest, a clear research goal 
is to identify compounds in the crude extracts that enhance the toxicity of 
pure compounds, and to identify whether any compounds in crude extracts 
can reduce the toxicity of pure compounds.  Therefore, assessments of one 
or several toxins may not be sufficient to characterize the risk posed by the 
mixture of cyanotoxins in a bloom.  This issue is of particular importance 
to the design of toxicological experiments whose aim is the provision of 
data to support regulatory limits for the toxins in drinking water. These ex-
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periments are universally done using pure toxins, but some consideration 
should be given to the inclusion of at least one treatment group receiving a 
crude extract for comparison. However, if such experiments demonstrate 
these hypothesized effects, then the range of compounds requiring detec-
tion may multiply considerably. 
Research Priority: Expand the use of toxicity screening assays 
with a focus on pathology-based and mechanism-based 
screening  
Pathology-based and mechanism-based toxicity screening 
Due to the lack of readily available, validated, analytical methods that are 
capable of detecting the range of cyanotoxins known to exist, and of refer-
ence standards for them, the workgroup prioritized the expansion of toxic-
ity screening assays with a focus on pathology-based and mechanism-
based screening assays.  Several approaches were suggested: 1) in vitro, 
utilizing cell-based assays and molecular techniques; 2) in vivo, such as the 
zebra fish egg test and various crustacean-based assays; 3) developmental 
screens involving fish or mouse embryos and; 4) assays that account for 
temporal effects.  Screening assays should be as simple and sensitive as 
possible.  Additional considerations are cost per assay and required techni-
cal expertise and resources. Screening assays may be used to detect toxins 
during occurrence surveys, to determine the environmental effects of the 
toxins, to determine the environmental factors that influence toxin produc-
tion, and to monitor water bodies used for drinking water.  Each of these 
uses will require the selection of an assay appropriate for the particular use 
and research need. 
As previously mentioned, the basic question of how to deal with mix-
tures arose as a major complicating factor in developing cyanotoxin 
screening methods.  Other factors to be considered are the effects of deg-
radation rates, pH, photolysis, and total organic carbon (TOC) on the as-
says.  Additionally, effects of toxins may have a temporal aspect that is not 
easily addressed by short-term in vitro assays.  The workgroup agreed that 
the advantage of toxicity screening methods is that they measure toxicity 
and do not just identify individual toxins.  This distinction is important be-
cause of the enormous toxicity differences between congeners.  Cyanobac-
teria frequently lose the ability to produce certain congeners during labora-
tory cultivation.  Therefore, it should be anticipated that results from field 
screening assays may differ from the more advanced laboratory analysis 
with cultured cyanobacteria. 
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Based on the Organisation for Economic Co-operation and Develop-
ment (OECD) Guideline for Testing Chemicals-Direction 210, the zebra 
fish egg test was proposed as a rapid and sensitive screening tool for 
evaluating cyanotoxicity with relevance to understanding the environ-
mental effects of these toxins.  Ongoing studies are evaluating the effects 
of cyanotoxins (purified and raw extracts) on zebra fish, and a future as-
sessment of these studies will help in evaluating the utility of this approach 
as a screening tool for cyanotoxicity.  Assays based on transfected mam-
malian cell-lines that rapidly detect the characteristic biochemical effects 
of the cyanotoxins are also being developed. It is expected that these will 
provide a diagnostic capability that will help identify the toxin(s) involved.  
Biochemical assays 
Biochemical assays have been published for a number of cyanotoxins. Ex-
amples include protein phosphatase inhibition assays for microcystins and 
a protein synthesis inhibition assay for cylindrospermopsin (CYN).  Sigma 
has developed a Protein Tyrosine Phosphatase (PTP) assay kit which can 
be used to screen for PP1 inhibitors, while Biosense (www.biosense.com) 
has a test kit in development that uses an immobilized PP2A active site as 
the receptor in a competitive binding assay micro-plate format.  
Antibody-based assays exist for the PSPs (Jellett Rapid Test for PSPs 
and Ridascreen ELISA for saxitoxin), but little work has been done so far 
to prove their efficacy for use with the range of congeners produced by 
freshwater cyanobacteria.  Established ELISA kits are available for micro-
cystins.  Various products have been evaluated previously (see AwwaRF 
report 2789).  An ELISA for CYN has recently been announced by 
Abraxis.  Biosensors embedded in semiconductor microchips may provide 
an alternative means of detecting the presence of cyanotoxins, instead of 
the current reliance on HPLC and ELISA-based assays.  Biochips for saxi-
toxin have already been developed, for example Dill et al. (2001). This 
publication demonstrates the ability of CombiMarix Corporation’s microar-
ray antibody chip to detect saxitoxins (http://www.combimatrix.com/).  
Aptamers specific for microcystin have been developed but assays based 
on them do not yet have the required sensitivity and specificity.  Assays 
based on artificially produced antibody fragments are also at the experi-
mental stage.  Although the sensitivity of biochips operating in reservoirs 
and water treatment facilities remains to be determined, the development 
of these biosensors represents an important area for future research.  A 
drawback of all antibody-based technologies is that affinity for the toxins 
does not correlate with toxicity, and new analogues may not be detected 
even though they are toxic (see AwwaRF report 2789). The development 
328
of a biosensor to assay only for a particular cyanotoxin would preclude the 
identification of the contaminating cyanobacteria since multiple genera 
may produce the same toxin.   
Availability of antibodies 
There are no readily available non-proprietary antibodies for saxitoxin 
(STX) or any of the other cyanotoxins, although a number of laboratories 
around the world have developed or are in the process of developing anti-
bodies for use in their own research or assay development.  Proactive steps 
should be taken to link these laboratories with kit makers so that assay de-
velopment can be accelerated.  The development of reliable assays is also 
contingent upon a previously identified priority – enhancing the supply of 
reliable chemical standards. 
Research Priority: Develop rapid PCR-based assays for the 
presence of specific cyanobacteria and the potential for 
production of specific toxins  
Molecular-based monitoring 
The in vitro molecular approaches based on the polymerase chain reaction 
(PCR) have advantages as screening tools for the presence of toxigenic 
species because they have the potential to yield more rapid and more sensi-
tive results (See Charge 5, below).  To select appropriate genetic markers, 
the Workgroup agreed that more genetic information is needed.  There are 
currently no whole genomes available for any toxin-producing cyanobacte-
ria.  Although the microcystin B biosynthetic gene cluster (mycB) is 
known, those encoding other cyanotoxins such as PSPs and cylindrosper-
mopsin are not yet known.  Molecular methods for assessing potential tox-
icity are limited by this lack of information. 
Generally, the technical expertise and resources required for PCR-based 
techniques are greater than that of a trained microscopist who identifies 
cyanobacterial cells, but are less than that of an analytical chemistry lab 
employing HPLC identification methods and that of a lab conducting tox-
icity screening assays.  Established techniques exist for using the genetic 
sequence of the 16S ribosomal RNA subunit to identify species of cyano-
bacteria. Some laboratories are developing assays that use the presence of 
toxin biosynthetic genes, such as mycB, to judge whether a bloom has the 
potential to produce toxins.  Every strain of cyanobacteria with the gene 
for toxin production is capable of producing toxins, but the conditions for 
toxin production may not be present.  Conversely, if the cyanobacteria lack 
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a gene for toxin production, no toxins will be produced.   To identify both 
toxicity genes and individual cyanobacteria, molecular screening assays 
should include toxin producing and genera- and species-specific bio-
markers.  Historical occurrence data, once developed, is invaluable in se-
lecting appropriate markers.  However, ecological theory suggests that as a 
region’s environmental conditions change, the organisms found in that re-
gion will also change.  This process is hypothesized to account for the 
northward spread of Cylindrospermopsis raciborskii that has been ob-
served as global warming continues.  
A key development in our ability to predict the occurrence of C-HABs 
has been the identification of the microcystin gene cluster (mycB).  This 
gene can be used as an indicator of potential toxin production, alerting wa-
ter quality managers to the possibility of a toxic bloom.  Reservoirs can be 
monitored by extracting DNA from whole algal communities, and testing 
for the presence of the microcystin gene by a PCR-based assay (e.g., His-
bergues et al. 2003).  A test for CYN-producing genes has also been pub-
lished (Fergusson and Saint, 2003). Similar tests would give additional 
warnings for the potential presence of other toxins, including saxitoxin and 
anatoxins.  However, the biosynthetic genes responsible for the production 
of these latter toxins are currently unknown.  In addition, genes that inter-
act with the toxin gene clusters remain to be fully described in Microcystis, 
and are completely unknown for the other organisms.  Whole genome se-
quencing, followed by bioinformatic analyses, is another approach that can 
be used to search for toxin gene clusters (see Charge 5 for a detailed dis-
cussion).   
Research Priority:  Develop molecular and toxicological 
fractionation methods to identify toxic components of raw 
water  
As described earlier in this report, many compounds might act synergisti-
cally to augment the effects of cyanotoxins.  Crude extracts from blooms 
often are more toxic than can be accounted for by their content of the puri-
fied component toxin(s).  This enhanced toxicity may be due to interaction 
with other (known or unknown) cyanotoxins or because there are other 
compounds that enhance toxicity.  These compounds may include water 
treatment byproducts, environmental/UV degradation byproducts, other 
toxic components in raw water, and bacterial metabolites.  Because our 
current knowledge of cyanotoxin interactions with other contaminants is 
limited, there is clearly a need for continued toxicity testing of any poten-
tial byproducts produced by treatments to improve water quality.  Simi-
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larly, we know very little of the reactive chemistry of cyanotoxins in ma-
trices, including their degradation chemistry and their physical and chemi-
cal reactions with sediment and other complex matrices. 
The approach of comparing the toxicity of crude cell extracts with that 
of purified toxins has been undertaken by several labs.  Such comparisons 
performed in vitro using cell cultures (preferably of human origin) are 
needed.  One hypothesis is that these unidentified compounds are ana-
logues of known cyanotoxins. This hypothesis should be evaluated in or-
ganic chemistry labs with an interest in secondary metabolites. The toxic-
ity of novel analogues should be assessed in isolation and in combination 
with known analogues. Immunoaffinity is an approach for distinguishing 
the effect of cyanotoxins from that of other compounds.  This approach 
was applied to microcystin.  The toxin was removed by binding to an im-
munoaffinity column containing antibody to microcystin (Kondo et 
al.1996), followed by toxicity assays of the separated eluents.  This ap-
proach could be expanded to cylindrospermopsin-producing cultures or 
blooms once suitable antibodies are available. An advantage of this method
is that the bound toxins can be easily recovered.  
Non-mammalian model systems that have provided information of rele-
vance to public health risk assessment include Xenopus oocytes and ze-
brafish.  Although these models aid our understanding of effects of 
cyanotoxins in the environment, any effects must ultimately be confirmed 
in at least one mammalian model system to assess risks to human health.  
Since in vitro experiments are limited by experimental constraints and dif-
ficulty of interpretation, it will be necessary to use mammalian model sys-
tems to confirm all hypothesized mechanisms of action.   
The above discussion notwithstanding, research prioritization requires 
some knowledge of the primary risks in a particular country or region.  Es-
tablished detection methods should be implemented to provide local 
cyanobacteria and cyanotoxin occurrence data. This approach focuses on 
common analogs, but substantial differences in toxicity or chemistry be-
tween the identified and unidentified analogs could lead to inaccurate as-
sessments of risk.  A comparison to the toxicity caused by the identified 
analogues and crude cell extracts can be used to assess the overall risk.  
Thus, the assessment of risk in local and regional areas may benefit from 
an on-going prioritization process. 
Characterization of unknown toxic compounds 
There is a high likelihood that novel cyanobacterial blooms and toxins will 
continue to emerge.  A key research priority will be the identification of 
unknown bloom-forming species and their toxins.  If a new, emerging 
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cyanobacterium (e.g. Lyngbya cf. confervoides on the coast of Florida), 
produces unknown toxins, standard chemical and toxicological methods 
are needed to separate and identify the toxic components.  Several labs 
working on natural products from cyanobacteria have established standard 
procedures for cyanobacterial culture, activity assay-based fractionation, 
and LC, MS, and NMR of unknown compounds.  These processes have 
proven fruitful in the past (see Table A.1 in Humpage this volume, and 
references cited therein).  These studies generally provide enough chemi-
cal information to enable the development of methods to identify the com-
pounds.  Although initial in vitro cellular or enzyme inhibition data may be 
obtained, further toxicological characterization of the compounds is 
needed to produce meaningful risk assessments.  
 
Recommendation:  Develop more local expertise to identify cyanobacteria 
and their toxins.  Several symposium attendees stated that their local water 
quality management teams do not have the expertise to identify cyanobac-
teria or cyanotoxins.  Education of local water quality agents will be 
needed to ensure that blooms of toxic organisms will be detected.  In addi-
tion, simple and fast procedures for toxin detection need to be distributed 
to local agencies.  Although ELISA-based detection kits are already avail-
able for microcystins, cylindrospermopsins, and saxitoxins (e.g. from R-
Biopharm), some local agencies were not aware of their existence.  Out-
reach and education to local water quality agencies will be needed to im-
plement any findings and recommendations of a national research plan. 
The development of predictive models for bloom and toxin occurrence is a 
long-term goal. 
Charge 1: Identify and prioritize research needs concerning the 
identification and quantification of cyanobacteria, cyanotoxins, 
and their toxicities. 
Near-term Research Priorities  
• Developing protocols to ensure the availability of reliable reference 
standards of cyanotoxins as well as antibodies for use in biochemical 
assays 
• Developing local expertise to identify cyanobacteria and their toxins 
• Developing PCR-based screening assays to identify cyanobacteria and 
the potential for toxin production; develop an ELISA assay for anatoxin-a
• Developing ways to increase the rapidity, sensitivity, specificity, and 
robustness of biological toxicity screening assays 
• Obtaining ecological and genetic information on mechanisms of toxin 
production and toxin regulation.   
Long-term Research Priorities  
• Developing biologically-based in-line, real-time biosensors for 
automated water quality monitoring 
• Assessing the interactions of cyanotoxins with complex mixtures and 
complex matrices, including identification of transformation byproducts 
of toxins resulting from water treatment and environmental or UV 
degradation 
• Developing a predictive model of the occurrence of C-HABs and toxic 
blooms. 
Charge 2: Toxicokinetics 
Identify and prioritize toxicokinetic research needed to improve hu-
man health risk assessments. 
 
Toxicokinetic research on cyanotoxins to date has been limited to basic 
studies of tissue distribution/elimination and initial efforts to characterize 
primary metabolism of the more prevalent toxins.  Determinations of the 
relative contribution of different exposure routes to total exposure, the role 
of metabolism in toxic responses and detoxification, and particularly, the 
characteristics of human toxicokinetics, are important endeavors for future 
research. 
Research Priority: Labeled compounds and antibodies are 
needed for Toxicokinetic studies 
Microcystins (MC) have been radioactively labeled in individual laborato-
ries as needed for research. The only exception is 3H- microcystin  (Robin-
son et al. 1989) that was labeled by Amersham for the Pathophysiology 
Division, United States Army Medical Research Institute of Infectious 
Diseases, Ft Detrick, Md.  Brooks and Codd (1987) grew Microcystis in 
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culture with sodium 14C-bicarbonate. This required exposure to radioactiv-
ity for long periods, and resulted in a labeled product with low specific ac-
tivity.  The method used by the majority of researchers for labeling MC is 
reduction of the methyl dehydroalanine residue by NaB3H4.  The products 
of reaction were characterized by Meriluoto et al. (1990) as retaining the 
toxicity of the native MC-LR with somewhat less potency. This labeled 
compound differs from native MC by not being able to form a covalent 
bond with protein phosphatase 1 and 2A (PP1 and PP2A): the targets of 
MC in cells and in vivo. Falconer et al. (1986) and Runnegar et al. (1986) 
labeled the tyrosine of MC-YM enzymatically with iodine 125 and showed 
that the monoiodinated product of the reaction retained the same toxicity in 
mice as the native MC-YM while the di-iodinated product had somewhat 
less potency. 
There is only one report of a labeled cylindrospermopsin. This deriva-
tive resulted from the growth of the cyanobacterium with sodium 14C-
bicarbonate: (Norris et al. (2001).  Radiolabeled saxitoxin (3H-STX) is cur-
rently available at no cost through a collaboration between FDA, NOAA 
and IAEA. 
Many antibodies have been prepared commercially that are incorporated 
into ELISA kits for the detection of MC in water.  Research groups have 
also developed antibodies to MC for use in their laboratories.  Commercial 
MC monoclonal antibodies are marketed by Alexis.  Dr. Michael Weller 
(Technische Universitat Munchen, Institut fur Wasserchemie) has investi-
gated the specificity of these antibodies towards MC-LR and other conge-
ners providing a good basis for their potential scientific use.  Nevertheless, 
the specificity of most of these antibodies needs further characterization.  
The degree to which antibodies detect MC when it is covalently bound to 
the protein phosphatases or tightly bound in the inhibitory complex is also 
unknown.  Matrix effects also have not been evaluated.  Antibody detec-
tion of congeners, metabolites, and degradation products following water 
treatment also requires study.  Metcalf et al. (2002) compared the cross-
reactivity of MC-LR, conjugates of three commercial ELISA kits, and an-
in house ELISA. Cross-reactivity for the compounds tested depended on 
the solvent used. Antibodies are used in the ALGAETOX project for the 
development of biosensor systems to detect and quantify algal blooms and 
toxins (TU Berlin, Fachgebiet Landsschatokologie, insbesondere Oko-
toxikologie).  With these caveats, antibodies have been used to detect MC 
in tissue/cells for immunochemical analysis and immunohistochemical lo-
calization as well as for some quantitation. 
A new ELISA kit for the detection of cylindrospermopsin via antibodies 
is now available from Biosense Laboratories. The antibody binds to CYN 
with no cross-reactivity with other non-related toxins or compounds. The 
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assay has a detection range between 0.05 and 2.0 ppb and can be used with 
a variety of environmental samples such as water and fish tissues.  Abraxis 
recently (Jan 2007) announced production of a CYN ELISA, but it is not 
known whether the antibodies are available separately. 
The production of stable standardized radiolabeled toxins and antibodies 
with known specificities are important near-term needs for toxicokinetics 
research. 
Research Priority: Classical toxicokinetics (distribution, half-
life, elimination, etc.) in laboratory animals 
Studies employing radiolabeled microcystins have demonstrated that the 
liver is the main site of toxin accumulation (after oral, intraperitoneal, or 
intravenous dosing) and that hepatic toxin concentrations remain relatively 
constant for up to 6 days after treatment.  These findings include: 30-40%  
of 125I-MC-YM dose in liver at death or 24 hr after i.p. injection (Runne-
gar et al 1986); 76% of 14C-MC-LR dose in liver at 1 min and 77% in liver 
at 60 min after i.p. injection (Brooks and Codd 1987); 56% of 3H-MC-LR 
dose in liver at death or 6 hr after i.p. injection (Robinson et al 1989); 30% 
of 3H- dihydro MC-LR dose in liver at 45 min after i.v. injection (Merilu-
oto et al 1990);  67% in liver of mice injected i.v. after1 hr and 6 d (Robin-
son et al 1991); and 47-65% of 3H- dihydro MC-LR dose in liver at 5 hr 
after i.v. injection of pigs (Stotts et al 1997).  Pretreatment with rifamycin 
(inhibitor of MC uptake in hepatocytes) decreased the hepatic MC concen-
tration after dosing and protected from MC toxicity if given 5 min before 
MC dosing (Runnegar et al. 1993). 
Small amounts in the kidneys, intestine, and carcass indicated that these 
differently labeled MCs all concentrated similarly in the liver, and that 
there was no significant loss of label from MC.  Mice had excreted 9 and 
15% of an i.v. dose in the urine and feces after 6 days, respectively.  Al-
though none of the labeled microcystins are ideal (see Meriluoto et al. 
1990 for a discussion), they all have similar organotropism, and subse-
quent work from many laboratories with animals, perfused livers, and iso-
lated hepatocytes confirmed the findings. 
Microcystin antibodies have been used for MC quantitation in tissues of 
treated mice and fish: (Liu et al. 2000; Guzman et al. 2003). Immunostain-
ing and semi-quantitative analysis in mice were reported by:  Yoshida et 
al. (1998), i.p. mice, liver accumulation; Yoshida et al (1997), oral in mice 
with liver accumulation; Ito et al. (2000), oral dosing with liver accumula-
tion in mice receiving a lethal dose.  Oral dosing showed some additional 
MC staining in the intestine.  Guzman et al. (2003) reported MC staining 
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in the nucleus as well as cytoplasm of hepatocytes in a section of mouse 
liver.  Liver accumulation was also shown in rainbow trout (Fischer et al. 
2000). 
Table 2. Tissue Distribution and Elimination of Radiolabeled Microcystin-LR in 
Mice 
Species  
& Route 
Dose &  
Isotope 
Time Tissues % of Dose Half Life 
Mice i.p. 45 µg/kg 
Sublethal 
&100 µg/kg 
Lethal 
6 hrs 
or death 
Liver 
Kidney  
Intestine 
Carcass 
>50 
1 
10 
10 
 
Mice i.p. 70 µg/kg 60 min Liver 
Kidney 
Intestine
60 
1 
9 
29 min 
Male  
Mice i.v. 
3
H MYC-LR 
 35 µg/kg 
Sublethal 
1 min Liver  
Intestine 
Kidney 
Carcass 
Plasma  
23 
5 
2 
30 
25 
"-phase: 0.8 min 
$-phase: 6.9 min 
Male  
Mice i.v. 
3H MYC-LR 
 35 µg/kg 
Sublethal 
60 min Liver  
Intestine 
Kidney 
Carcass 
Plasma  
67 
9 
1 
6 
trace 
 
Male  
Mice i.v. 
3H MYC-LR 
 35 µg/kg 
Sublethal  
 
 6 days Urine 
Feces 
Liver 
9 
15 
67 
Covalently bound 
in liver cytosol: 
Day 1 - 83%  
Day 6 - 42% 
Adapted from Robinson et al. (1989, 1991) 
 
14C-labeled cylindrospermopsin was administered i.p. to mice resulting 
in excretion of CYN mainly in the urine but also in the feces (Norris et al. 
2001). The excretion patterns showed substantial inter-individual variabil-
ity between predominantly fecal or urinary excretion, but excretion pat-
terns were not related in any simple manner to toxicity.  The authors also 
found CYN in the liver: 21% of dose at 6 hrs and 13% at 48 hr.  Additional 
evidence indicated CYN or a metabolite was tightly bound to protein.  
Analysis by HPLC indicated that this tightly bound CYN was in part a hy-
drophilic metabolite with a different elution time.  This single report shows 
the complexity of CYN distribution, metabolism and excretion.  Much 
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more work is needed to confirm and extend the findings particularly given 
the intra-mouse variability reported. 
Toxicokinetic and toxicodymanic studies have been performed for saxi-
toxins (STXs) in cats (Andrinolo et al. 2002). Oral doses of gonyautoxins 
2/3 were administered to cats to determine how toxins are absorbed in the 
digestive system, where they are absorbed, the absorption rate, the maxi-
mal concentration in the plasma, and the time needed to reach that maxi-
mum. Oral uptake was efficient, toxin distributed rapidly throughout the 
body (including the brain), was cleared by simple glomerular filtration, 
and there was no evidence of metabolism of the toxins. Urine appears to be 
a major route of toxin excretion in humans (Gessner et al. 1997).  The toxi-
cokinetics of saxitoxinol in rats has also been investigated (Hines et al. 
1993; Naseem 1996). 
β-Methylamino alanine (BMAA) toxicokinetic studies in rats and mon-
keys demonstrated rapid and virtually complete uptake via the oral route, 
and distribution throughout the body (Duncan et al. 1991; 1992). The brain 
contained only about 0.08% of the administered dose at 48 hrs. There was 
evidence of active transport across the blood-brain barrier via the large 
neutral amino acid carrier (Km=2.9mM), but this would not be rapid when 
BMAA is in competition with normal levels of natural amino acids (Dun-
can et al. 1992; Jalaludin and Smith 1992). Approximately 1.4% of an oral 
dose, and 1.8% of an i.v. dose, were excreted unmetabolized in the urine 
by 48 hrs, whereas approximately 22% could be accounted for in total as 
either unmetabolized or acid hydrolysable (Duncan et al. 1992; Jalaludin 
and Smith 1992; Humpage this volume). L-amino acid oxidase has been 
shown to metabolize BMAA, eventually leading to N-methylglycine, but 
the rate appears to be quite slow (Hashmi and Anders 1991). The racemate 
and L-forms of BMAA caused cerebellar dysfunction and degeneration of 
GABAergic cells, presumably through excitotoxicity, but multiple low 
doses of racemate did not shown evidence of cumulative toxicity (Seaw-
right et al. 1990). 
Transport 
Microcystins.  Microcystins require transport via specific organic anion 
transport proteins to cross cell membranes (Runnegar et al.1993; Runnegar 
et al. 1995a; Fischer et al. 2005).  Many studies have shown uptake of MC 
by active transport in hepatocytes but not in other cells including hepatic 
nonparenchymal cells. There is a good correlation between MC accumula-
tion and toxicity.  Hepatocytes from rats and mice as well as from many 
aquatic animals have been studied.  The organ specificity of MC is due to 
transporters that predominate in the liver. MCs can inhibit protein phos-
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phatase activity with similar potency in cell/tissue extracts from any eu-
karyote tested so far.  The uptake of MC is inhibited by bile acids and 
dyes.  Perfused livers and whole animals were protected from toxicity if 
pretreated with these compounds. 
 Very recently the transporters that mediate MC uptake were identified, 
opening the possibility for many new studies (Fischer et al. 2005).  
Xenopus laevi oocytes were injected with complementary RNA of the 
known multi-specific organic anion transporting polypeptides (OATPs), 
and uptake of 3H-dihydro MC-LR was measured. Three human OATPs 
were shown to mediate the transport of MC: OATP1B1 (was OATPC), 
OATP1B3 (was OATP8) and OATP1A2 (was OATPA). The first two are 
mainly expressed in liver, thus explaining the MC uptake inhibition in 
hepatocytes by bile salts and other compounds (substrates or inhibitors of 
OATPs), as well as the protection by predosing with rifamycin in vivo 
(Runnegar et al. 1993).  The third transporter is also expressed at the 
blood-brain barrier.  This finding indicates the possibility of MC uptake by 
the brain. Brain uptake of MC by OATP1A2 cannot be tested directly be-
cause the enzyme is of human origin. However, research in several labs on 
whole body distribution using radioactive MC (four differently labeled iso-
topes) indicates that brain uptake must be very low.  Nevertheless, this is-
sue and the possibility of equivalent transporters in the rat and mouse 
should be examined.  As a first step, mammalian/human cells transfected 
with the OATP1A2, or any other cell that expresses the transporter, should 
be tested for MC uptake and intracellular changes such as protein phos-
phatase activity inhibition and cytoskeletal damage.  It is also necessary to 
confirm that cell lines expressing those OATPs as found in liver can take 
up MC with activity similar to that found in hepatocytes. 
 
Cylindrospermopsin.  It is thought that CYN permeates membranes in all 
cells, although further experimental demonstration is needed. This can be 
accomplished only when radiolabeled CYN becomes available. There is 
some indication that hepatocytes are more sensitive to CYN toxicity than 
other cells. This could be due to differences in metabolism and/or uptake. 
Research Priority: Determine the role of metabolism in toxicity 
and detoxification 
The accepted pathway for microcystin excretion is conjugation to the thiol 
of glutathione (GSH).  This may be excreted as MC-GSH or processed to 
the gamma glutamyl cysteine conjugate and finally to the cysteine conju-
gate, and then excreted.  These reactions have been shown to occur enzy-
matically in vitro with cell extracts from many sources (i.e., Pflugmacher 
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et al. 1998, Pflugmacher et al. 2001, Takenaka 2001).  This is the most 
likely in vivo pathway given the changes in GSH peroxidase and in GSH 
transferases that follow MC dosing.  Evidence of this pathway in intact 
cells or in vivo after MC dosing includes detection and identification of 
MC metabolites formed in vivo in mouse and rat liver (Kondo et al. 1992, 
Kondo et al. 1996). The GSH adduct (through nucleophilic reaction of the 
thiol group of GSH to the alpha-beta unsaturated carbonyl of the Mdha 
moiety (methyl dehydroalanine)) was formed as a small (not specified) 
percentage of the dose in mice injected i.p. with MC-RR (LD50) between 3 
and 24 hr.  Sipia et al. (2002) and Karlson et al (2003) reported the pres-
ence of the GSH conjugate of nodularin as well as native nodularin in 
mussels and flounders off the Finnish coast.  A nodularin conjugate has 
also been found in Artemia salina (Beattie et al. 2003).  Wiegand  and 
Pflugmacher (2005) reported that MC-GSH has a lower affinity for protein 
phosphatase than the native MC.  Although MC excretion in mammals has 
been proposed to be mainly intestinal, the chemical nature of excreted MC 
has not been determined.  Experimental studies are needed to determine 
and quantify the metabolism and excretion of MC and metabolites.  
There is evidence for metabolic activation of cylindrospermopsin: in-
hibitors of CYP450s reduce CYN acute toxicity (Runnegar et al. 1994, 
Froscio et al. 2003), genotoxicity (Humpage et al. 2005), and CYN-
dependent inhibition of glutathione synthesis (Runnegar et al. 1995).  As 
noted above, Norris et al. (2001 and 2002) found evidence of CYN/or me-
tabolite binding to protein in the liver, and HPLC analysis indicated that 
this tightly bound CYN derivative was in part a hydrophilic metabolite 
with a different elution time.  For both MC-LR (and congeners) and CYN, 
research is needed to characterize the formation, chemical nature, and tox-
icity of metabolites in animals and humans. 
Exposure experiments indicated that fish are susceptible to saxitoxins 
when administered orally or by i.p. injections, and cytochrome P4501A 
was induced, suggesting a role for the enzyme in saxitoxin metabolism 
(Gubbins et al. 2000).  Saxitoxin composition and concentrations in mus-
sels and human biological specimens demonstrated that toxin metabolism 
in humans occurs.  Following a human fatality associated with consump-
tion of crabs contaminated with saxitoxins, toxin compositions in the crab 
and clinical samples (human gut, liver and urine) indicated that toxin me-
tabolism occurred and that toxin conversion began in the victim’s gut 
(Llewellyn et al. 2002). 
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Charge 2: Identify and prioritize toxicokinetic research needed 
to improve human health risk assessments. 
The recent Harmful Algal Research and Response plan (HARRNESS 
2005) indicates top priorities for biosynthesis and metabolism research in-
clude: 1) identifying metabolites that contribute to animal or human ill-
ness; 2) identifying metabolites that are useful as biomarkers for longer 
term exposure and; 3) providing toxicological and pharmacokinetic infor-
mation on HAB toxins and metabolites to help determine toxin uptake, 
metabolism, and clearance rates. We concur with these research needs and 
further delineate research priorities as follows: 
Near-term Research Priorities 
• Provide labeled compounds and better characterized antibodies for 
toxicokinetic studies 
• Develop standardized methods for sample preparation for analysis of 
toxins/metabolites in complex matrices (tissues) 
• Classical toxicokinetics (distribution, half-life, elimination, etc.) in 
laboratory animals 
Long-term Research Priorities 
• Determine role of metabolism (if any) in toxicity and detoxification 
- Identify metabolites for priority toxins 
- Mixtures issues: do toxins share common metabolic pathways; are 
enzymes induced or inhibited that could affect toxicity of other toxins 
or repeated exposures? 
- Is the promotion of oxidative stress an additional toxic factor of 
cyanobacterial toxins? 
- Human in vitro metabolism (tissue, cell and enzyme specific studies) 
• Apply toxicokinetic methods to describe exposure route-dependent and 
species-specific differences in toxicity 
- Develop physiologically-based toxicokinetic models for priority 
toxins 
• Developmental toxicokinetics 
- Describe transport of priority toxins across placenta 
- Describe the toxicokinetics of saxitoxin in developmental neuro-
toxicity 
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Charge 3: Toxicodynamics 
Identify and prioritize toxicodynamic research needed to improve 
human health risk assessments. 
Research Priority: Assess dose-response relationships and 
mechanisms with a focus on low concentration exposures 
including both in vitro and in vivo studies as appropriate 
Acute Toxicity and Known Mechanisms 
Microcystins.  Microcystins cause adverse effects by rapidly binding and 
inhibiting the activity of ser/thr protein phosphatases PP1 and PP2A. The 
inhibition is irreversible and its consequences are well characterized for 
acute toxic doses (Ito et al. 2002).  MC-LR has a LD50 (i.p., mice, 24hr) of 
60 μg/kg. The primary acute effect of protein phosphatase inhibition is hy-
perphosphorylation of many cellular proteins including the hepatocellular 
cytoskeleton, which causes loss of cell-cell contacts and thus intra-hepatic 
hemorrhage. Death is due to hypovolemic shock (Runnegar and Falconer 
1986; Falconer and Yeung 1992; Runnegar et al. 1993).  Other acute ef-
fects include altered mitochondrial membrane permeability, generation of 
reactive oxygen species, and induction of apoptosis (Fladmark et al. 1999; 
Humpage and Falconer 1999; Ding et al. 2000; Hooser 2000), likely due to 
a fatal loss of control of regulatory phosphorylation. Morphological 
changes have been characterized using histopathologic and electron micro-
scopic techniques in rodents, pigs, sheep, and chickens. The Caruaru 
hemodialysis incident in Brazil extended these findings to humans (see 
Jochimsen et al 1998; Pouria et al. 1998; Azevedo et al. 2002; Soares et al. 
2006; Yuan et al. 2006).  
Bulera et al. (2001) showed by toxicogenomic analysis that a non-lethal 
i.p. injection of MC-LR in male rats resulted in a distinctive pattern of 
gene expression change when probed by microarray with 1600 rat genes at 
3 and 6 hrs after dosing. The pattern differed from that seen with other 
well characterized liver toxins. The dose of MC (50 µg/kg) did not cause 
any detectable histological change. This is consistent with the changes in 
liver function such as receptor-mediated endocytosis that is seen in hepa-
tocytes at doses of MC-LR that cause no significant cytoskeletal changes 
(Hamm-Alvarez et al. 1996; Runnegar et al. 1997).  Although MCs may 
affect cellular activities independent of the phosphatase inhibition, the im-
pacts of protein phosphatase inhibition may directly or indirectly account 
for hepatocyte functional alterations, oxidative stress, apoptosis, and 
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changes in gene expression.  Protein phosphorylation status plays a critical 
role in cellular signaling and hence all aspects of cellular function. In addi-
tion a number of these effects are also found in cells treated with other 
chemically distinct protein phosphatase inhibitors such as okadaic acid 
(see Gehringer 2004 for a review). 
Protein phosphatase inhibition by MC is mediated principally by the 
ADDA group (Goldberg et al. 1995), although most microcystin variants 
contain dehydroalanine which can covalently link to a cysteinyl sulphur on 
the phosphatase (Humpage this volume).  Congeners of MC-LR with an 
intact ADDA will also inhibit protein phosphatases. The covalent binding 
of N-methyl dehydroalanine to cys is secondary in protein phosphoryla-
tion, but is important in the metabolism of MC.  GSH competes for bind-
ing at the N-methyl dehydroalanine to form the GSH conjugate of MC.   
 
Cylindrospermopsin – cytotoxicity.  LD50 experiments with CYN indicate 
a delayed toxicity (2.0 mg/kg, i.p. mouse, after 24 hrs but 0.2 mg/kg after 5 
days; Ohtani et al. 1992). The pathology caused by CYN has been studied 
by light and electron microscopy in male mice dosed i.p. or orally. The 
liver and kidney were the organs most affected (Falconer et al.1999). 
Acute CYN poisoning results in lipid accumulation in the liver followed 
by hepatocellular necrosis (Terao et al. 1994; Seawright et al. 1999). Non-
hepatic effects include destruction of the proximal tubules of the kidney 
(Falconer et al. 1999), as well as cytotoxic and thrombotic effects in other 
tissues.  In addition, CYN extract caused varying lesions in other organs as 
reported earlier (Hawkins et al. 1985).  Sub-chronic oral exposure resulted 
in mainly hepatic and renal effects (Humpage and Falconer 2003). Effects 
of poisoning in humans included hepatoenteritis and renal insufficiency 
(Byth 1980). 
Native CYN has been shown to be a potent and irreversible inhibitor of 
protein synthesis at the translation step (Froscio et al. 2001; Runnegar et 
al. 2002; Froscio et al. 2003).  It has also been shown to inhibit GSH syn-
thesis (Runnegar et al. 1995b).  However, cell death and the pathology in 
CYN-dosed animals cannot be explained fully by protein and GSH synthe-
sis inhibition. Further, there is protection from CYN toxicity by cyto-
chrome P450 inhibitors (Runnegar et al. 1995b; Froscio et al. 2003). The 
best interpretation is that a CYN-derived metabolite formed by a P450-
catalyzed reaction is responsible for increased and/or different toxicity 
compared to that caused by the parent CYN. This is in agreement with the 
finding that the LD50 is lower (more toxicity) at 7 days than after one day in 
mice (Hawkins et al. 1985; Ohtani et al. 1992; Froscio et al. 2003).  Per-
haps the early toxicity is due to P450-dependent activation, and the later 
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toxicity is the result of protein synthesis inhibition or a combination of the 
two effects. 
 Chemical intermediates in the synthesis of CYN showed that the sulfate 
ester is not necessary for toxicity since the CYN-DIOL (lacking the sul-
fate) inhibited protein synthesis in hepatocytes with the same potency of 
native CYN.  The orientation of the C-7 hydroxyl did not matter as the 
epimer was toxic with similar potency (Runnegar et al. 2002). More re-
cently it was found that synthetic deoxy-CYN (lacking the hydroxyl group 
at C-7), like natural deoxy-CYN, retains the toxicity of CYN (Looper et al. 
2005).  Treatment of CYN with chlorine yielded 5-chloro-CYN and cylin-
drospermic acid.  These degradation compounds were shown to have at 
least 50-fold less toxicity than intact CYN in a mouse bioassay (Banker et 
al. 2001).   
In contrast to MC, more work needs to be done to determine the mecha-
nism of toxicity of CYN both in vitro and in vivo.  At present, neither the 
structural determinants of CYN toxicity nor the cellular targets of CYN 
have been elucidated. Effects of cylindrospermopsin on non-hepatic tissues 
have not been well investigated. Renal effects seemed to be important after 
chronic low dose exposure (Humpage and Falconer 2003), and thrombotic 
effects have been described by a number of researchers. Preliminary re-
sults from reproductive and teratogenic toxicity assessments indicate that 
larger studies will be required. 
 
Cylindrospermopsin – genotoxicity.  Cylindrospermopsin has been shown 
to be genotoxic in various in vitro assay systems. Concentrations of 1 – 10 
μg/ml (2.4 – 24 μM CYN) caused DNA fragmentation and loss of whole 
chromosomes in the cytokenesis-blocked micronucleus assay using the 
human white blood cell-line WIL2-NS (Humpage et al. 2000a). However, 
CHO K1 cells did not show this effect when exposed to 1.2 – 2.4 μM CYN 
(Fessard and Bernard 2003). To investigate the role of metabolism in this 
discrepancy, genotoxicity was studied in primary mouse hepatocytes 
(Humpage et al. 2005).  Cylindrospermopsin-induced DNA fragmentation, 
as detected by the COMET assay, was seen at CYN concentrations as low 
as 0.05 μM, well below the cytotoxicity EC50 of 0.5 μM. Genotoxicity was 
eliminated by application of the CYP450 inhibitors omeprazole (100 μM) 
or SKF525A (50 μM) (Humpage et al. 2005), indicating that a CYN me-
tabolite probably induces DNA fragmentation.  More recently, a range of 
standard in vitro assays have been used to confirm that DNA fragmenta-
tion is the major mechanism leading to genotoxicity (Humpage this vol-
ume).  Research is needed to identify metabolic pathways and toxic me-
tabolites that produce acute toxicity and genotoxicity.  There is consi-
derable evidence for involvement of CYP450s, but the specific isoforms 
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have not been identified.  Isoform identification is needed to determine 
whether toxic biotransformation pathways occur in humans and to assess 
the applicability of animal data to human risk. 
In vivo, DNA fragmentation was described in the livers of mice treated 
with cylindrospermopsin (Shen et al. 2002). Intra-peritoneal injection of a 
single dose of 0.2 mg CYN/kg induced an increase in hepatic DNA strand 
breakage within 6 hours that normalized by 72 hours. Evidence from 32P-
post-labeling experiments using the livers of CYN-treated mice also sug-
gested that DNA adducts are formed (Shaw et al. 2000).  
 
Saxitoxins.  The saxitoxins are potent voltage-gated sodium channel an-
tagonists, causing numbness, paralysis and death by respiratory arrest.  
Analogue potency varies greatly, with saxitoxin having an LD50 (i.p. 
mouse) of 10 μg/kg, but saxitoxin C1 being at least 160-fold less toxic 
(Oshima 1995). Toxicological studies to date have assessed acute exposure 
effects, as would be expected from shellfish poisoning. Repeated, low-
level exposure studies are needed to assess effects from drinking water ex-
posure (Humpage this volume).  Research is needed to verify and extend a 
report that tolerance to PSPs develops (Kuiper-Goodman et al. 1999). 
Mammalian studies are needed to extend a demonstration of neuro-
developmental disturbances in fish (Lefebvre 2002). 
Toxicodynamic studies have been performed for gonyautoxins (GTXs) 
in cats to assess their toxic effects and intoxication illness in mammals 
when administered orally (Andrinolo et al. 2002).  The primary physio-
logical effect was a dramatic decrease in arterial pressure, which eventu-
ally resulted in death.  Oral doses of 35 μg/kg of GTX 2/3 epimers and a 
plasma level of 36 ng/ml were the lethal limits for cats.  The specific bind-
ing of saxitoxin to brain tissue of mammals (Trainer and Baden 1999; 
Llewellyn et al. 2004; Cianca et al. 2007) and sub-lethal, short term expo-
sure of dissolved saxitoxin to larval fish (Lefebvre et al. 2004) have also 
been examined. In rats dosed i.p. with 5 or 10 μg saxitoxin/kg body wt, 
saxitoxin was bound to sodium channels in all brain regions at ppm levels.  
Larval fish exposed to dissolved saxitoxin exhibited reductions in sensory-
motor function after 48 h and paralysis by 4 days.  Larval exposure also re-
sulted in reduced growth and survival of the fish several weeks later. 
 
Nodularins.  Nodularins are hepatotoxic cyclic peptides of similar structure 
to the microcystins, containing 5 amino acids rather than 7 (Rinehart and 
Namikoshi 1994). ADDA is still present but dehydroalanine is replaced by 
N-methyl-dehydrobutyrine (Rinehart et al. 1988). The smaller ring size 
prevents this latter moiety from coordinating with the phosphatase cys-
teine, preventing nodularin from bind covalently (Lanaras et al. 1991; 
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Craig et al. 1996; Bagu et al. 1997). However, due to the high affinity of 
ADDA for the active site, this lack of covalent binding does not affect 
toxin potency, which is similar to that of microcystin-LR (Ki’s are of the 
order 0.1 – 1.5 nM; (Honkanen et al. 1990; MacKintosh et al. 1990; Hon-
kanen et al. 1991)). The lack of covalent binding may allow nodularin to 
reach other sites in the cell, a mechanism by which nodularins may act as 
direct carcinogens (Ohta et al. 1994; Bagu et al. 1997; Humpage this vol-
ume).  
 
Anatoxin-a/Homoanatoxin-a.  These toxins are nicotinic acetylcholine re-
ceptor agonists having a LD50 of 200 μg/kg (Carmichael et al. 1979; Car-
michael 1994). Residence of these toxins at post-synaptic cholinergic re-
ceptors results in nerve depolarization (Swanson et al. 1990; Huby et al. 
1991; Swanson et al. 1991; Wonnacott et al. 1991). Typical symptoms in 
mice are loss of muscle coordination, gasping, convulsions, and death 
within minutes from respiratory arrest (Carmichael et al. 1979).  Dog 
deaths have been attributed to poisoning by these toxins when the animals 
have licked their coats after swimming (Codd et al. 1992; Edwards et al. 
1992; Falconer and Nicholson, pers. comm.).  A single human fatality was 
attributed to anatoxin-a poisoning by a county coroner after the victim 
swam in a scum-covered pond (Behm 2003).  Although anabaena was 
identified in stool from the victim and another swimmer who became ill 
but survived, mass spectrometric analyses for anatoxin-a in blood were in-
conclusive (Carmichael, pers. comm.).  The peaks for anatoxin-a and the 
indigenous amino acid, phenylalanine, occur in the same portion of the 
spectrum because these compounds are isobaric and elute similarly in re-
versed phase liquid chromatography (Furey et al. 2005).  Anatoxins have 
not been linked to human poisoning via drinking water (Humpage this vol-
ume). 
Anatoxin-a(s).  Anatoxin-a(s) is a phosphorylated cyclic N-hydroxy-
guanine, with a structure and action similar to organophosphate pesticides 
(Mahmood and Carmichael 1986, 1987; Hyde and Carmichael 1991). It is 
a potent acetylcholinesterase inhibitor with a LD50 (i.p., mouse) of 20 
μg/kg. The in vivo toxic effects are similar to those of anatoxin-a but with 
the addition of salivation (hence the “s”) and lacrimation (Mahmood and 
Carmichael 1986, Carmichael 1987, Matsunaga et al. 1989). No human ill-
ness has been attributed to this toxin (Humpage this volume). 
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Research Priority: In vitro and in vivo studies of chronic and 
repeated exposures 
Subchronic and Chronic Toxicity 
Microcystins.  Reliable in vitro data are lacking because hepatocytes lose 
the transporters for MC with time in culture; thus, repeated/continuous ex-
posure is not possible. This problem can now be overcome in part by using 
other cell lines that have been transfected to express the newly identified 
transporters.  The effects of low doses of MC have been studied over a pe-
riod of 65 hrs (Humpage and Falconer 1999). The authors reported a dose 
dependent (10-100 pM) balance between proliferation and apoptosis of 
hepatocytes in culture.  Lower microcystin doses appeared to affect cell 
cycle control by suppressing apoptosis and promoting cell division in 
polyploid hepatocytes in vitro (Humpage and Falconer, 1999; Lankoff et 
al. 2003). Microcystin has also been shown to inhibit DNA repair (Lankoff 
et al. 2004; 2006a,b).  These effects are consistent with the tumor promo-
tion seen in in vivo studies, such as enhancement of the growth of hepatic 
and colonic pre-cancerous lesions in animal models (Fujiki and Suganuma 
1993; Ito et al. 1997a; Humpage et al. 2000b; Sueoka et al. 1997).  Micro-
cystin exposure has been linked to human liver and colon cancer incidence 
(Yu 1995; Fleming et al. 2002; Zhou et al. 2002). Using an intestinal crypt 
cell line, Zhu et al. (2005) explored the mechanism of tumor promotion 
that is shared by MC and chemically unrelated protein phosphatase inhibi-
tors such as okadaic acid, and showed that MC transformed these cells. 
Transformation is an important step in the development of carcinogenesis. 
These cells also had increased proliferation, and the authors went on to 
show that MC treatment resulted in increased expression and activity of 
proteins that control cell cycle signaling such as Akt, JNK and MAPK 
pathways.  This study also provides a mechanistic explanation for the hy-
perplasia in the colon seen in mice initiated with azoxymethane and then 
exposed to MC in the drinking water for 212 days (Humpage et al. 2000b).  
To date, findings for MC do not clearly and unequivocally demonstrate a 
potential for carcinogenicity.  The substantial evidence of tumor promotion 
by MC has recently led the Agency for Research on Cancer (AIRC) to 
classify MC-LR as “possibly carcinogenic to humans” (Group 2B).  A 
summary of this evaluation has been published (Grosse et al. 2006), and a 
full report will be published as an AIRC monograph.  
A number of rodent studies (and one pig study) with repeated dosing of 
MC or bloom extracts containing MC have been reported. Some of these 
studies have been used to calculate reference doses (tolerable daily in-
takes), LOAELs and NOAELs. These will be addressed by other groups.  
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We have some indication of the effect of repeated sublethal dosing: daily 
i.p. dosing with MC-YM for up to 28 days resulted in mild liver damage 
(Elleman et al. 1978).  Bloom extract given over 1 year orally to mice 
caused liver changes at the higher doses and some indication of increased 
incidence of tumors (Falconer et al. 1988).  Oral consumption of MC con-
taining cells by pigs for 8 weeks resulted in dose dependent liver toxicity 
(Falconer et al.1994).  Miniosmotic pump continuous administration of 
MC-LR in male rats for 28 days resulted in dose dependent increases in 
hepatic oxidative stress, in several serum biochemical toxicity indicators, 
and in histopathology that correlated with protein phosphatase inhibition 
(Solter et al. 1998; Guzman and Solter 1999).  Oral and i.p. dosing of mice 
with MYC-LR caused dose-dependent liver lesions, but no evidence of de-
velopmental toxicity in pregnant females (Fawell et al. 1999).  No toxicity 
was observed in female mice dosed orally with 20 µg/L of MC-LR over 18 
months (Ueno et al. 1999).   
 
Cylindrospermopsin.  Oral toxicity of low levels of CYN have been inves-
tigated by Humpage and Falconer (2003) in mice over 10-11 weeks. Dos-
ing with a Cylindrospermopsis culture extract and with CYN indicated that 
toxic changes were dose dependent with the kidney being most sensitive to 
the toxin. In addition, a study by Falconer and Humpage (2001) showed 
the potential for carcinogenicity of CYN-containing culture extracts.  Male 
mice were observed for 30 weeks after three sublethal doses of C. racibor-
skii extract were given orally over a 6 week period followed by treatment 
with TPA. At the dose used (equivalent of 2.75 to 8.25 mg CYN), the mice 
exhibited none of the histological changes seen in acute CYN toxicity. 
However, this treatment appeared to induce the formation of overt cancers 
in the mice by 30 weeks.  Five of 53 treated mice developed neoplastic le-
sions whereas none of 27 controls did so. The odds ratio for carcinogenesis 
following CYN treatment was 6.2, but the 95% confidence interval on this 
estimate was 0.33 to 117, a statistically insignificant result (p=0.16).  Nev-
ertheless, this study presents the clearest evidence yet that cylindrosper-
mopsin is not only genotoxic but may also be carcinogenic, which has im-
plications for low-level repeated exposures to CYN.  The potential 
carcinogenicity of CYN needs to be investigated in a larger study. Because 
this study used Cylindrospermopsis culture material, it is not possible to 
state that CYN alone was the causative agent. The potential carcinogenic-
ity of CYN and of CYN containing extracts should be investigated in a 
larger number of animals, as well as in a non-rodent species. Cylindros-
permopsin has been placed on the ‘candidate list’ for full toxicological 
studies by the USEPA and NIEHS. This can only be accomplished if large 
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amounts of CYN and CYN containing extracts are prepared and made 
available. 
Research Priority: Cyanotoxin Mixtures  
An important point to reiterate is that single microcystins or single cylin-
drospermopsins almost never occur in nature. Instead mixtures of toxins 
are the norm, so there is a need to understand toxin interactions. This will 
enable the calibration of studies done using MC-LR and the formulation of 
regulations to be based on toxicity equivalents rather than quantities of in-
dividual compounds. 
Crude extracts from blooms have been found to be more toxic than the 
purified component toxin(s).  This is probably due to the presence of other 
congeners or classes of toxins that enhance toxicity.  Similar patterns ap-
pear in many studies of chemical ecology (Paul et al. 2001).  Other com-
pounds present in minor concentrations may have additive or synergistic 
effects with the pure compounds of interest.  A research need is to charac-
terize the compounds in crude extracts that enhance the toxicity of pure 
compounds, and to identify whether any compounds in crude extracts can 
reduce the toxicity of pure compounds. An additional research need is to 
characterize interactions between cyanotoxins and other bioactive com-
pounds in raw and finished water such as metals or disinfection byprod-
ucts. 
Charge 3: Identify and prioritize toxicodynamic research 
needed to improve human health risk assessments. 
General 
• Determine effects from low concentration exposures starting with in 
vitro studies,  proceeding to in vivo studies as appropriate. 
• In contrast to MC, more work needs to be done to determine the 
mechanism of toxicity of CYN both in vitro and in vivo, including the 
structural determinants of CYN toxicity and the cellular targets of CYN.  
• Studies are needed to assess the effects of repeated and chronic 
exposures to individual cyanotoxins and appropriate mixtures. 
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Mixtures  
Near-term Research Priorities 
• Mixtures of toxins are the norm, so we need to understand toxin 
interactions. 
- Priorities are mixtures of microcystins and cylindrospermopsin 
- Use a priori information (regional occurrences) to prioritize 
candidate mixtures  
 
Long-term Research Priorities 
• Congener mixtures, especially effects of mixtures of microcystin 
analogues 
• Determine and characterize compounds in the crude extracts that 
enhance the toxicity of pure compounds, and identify whether any 
compounds in crude extracts can reduce the toxicity of pure compounds. 
Individual Toxins 
• Microcystins: Near-term Research Priorities 
- Analog mechanisms (including non-toxic ones) in comparison to 
MCY-LR 
- Comprehensive studies of teratogenicity and reproductive toxicity 
- Chronic animal studies to assess carcinogenicity (ideally these studies 
should test cyanobacterial extract that may contain modifiers of 
toxicity (as would be present in water) and with purified MC 
 
• Microcystins: Long-term Research Priorities 
- Epidemiological studies into links with human cancer. This requires a 
biomarker of low dose exposure for which ELISA may be an option 
(Hilborn et al. 2005).  
- Long term repeated dosing studies are needed in species other than 
rodents 
- Evaluate effects of modified MCs (and other cyantoxins) produced as 
byproducts of water treatment 
• Cylindrospermopsin: Near-term Research Priorities 
- Genotoxicity mechanism including the role of specific CYP450 
isoforms in CYN activation and identification of genotoxic meta-
bolites 
- Identification of biomarkers of exposure and effect 
- In vivo carcinogenicity trials when adequate pure toxin is available 
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- Detailed toxicokinetics, including distribution and binding studies are 
needed to explain the observed delayed toxicity 
- Studies of extra-hepatic effects including renal, thrombotic, 
immunologic, reproductive, and developmental effects 
- Human effects – An opportunity exists for follow-up of exposed 
humans on Palm Island, Australia 
• Anatoxins and Saxitoxins 
- Chronic low dose exposures/neural developmental toxicity mech-
anisms (near-term research priority) 
- ATXa(s) – studies comparing ATXa(s) and organophosphate 
pesticide toxicity (longer-term research priority) 
• BMAA: Near-term Research Priority 
- Further assess the association with neurodegenerative disease (Cox 
and Sacks 2002) 
• BMAA: Long-term Research Priorities 
- Mechanism of bioaccumulation. 
- Mechanism of toxicity (glutaminergic excitotoxicity or other effects 
such as disruption of protein structure/function).  
- Trophic studies to determine routes of human exposure.  
• Lower priority 
- Nodularins – use microcystin as model 
- Lyngbya toxins 
Charge 4: Susceptibility 
Identify and prioritize research needed to improve our understanding 
of human susceptibility factors for adverse effects from cyanotoxin 
exposure. 
Factors affecting susceptibility to cyanotoxins have generally not been in-
vestigated for the majority of the toxins.  The elucidation of toxic mecha-
nisms as described above within the toxicokinetics and toxicodynamics 
charges will provide direction and insights for research on susceptibility.  
Comparative toxicology studies of microcystins have yielded some find-
ings relevant to susceptibility, as summarized below. 
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In vivo Differences in Responses to Microcystins 
There is evidence that nutritional status, sex, age, and strain of laboratory 
animals can influence the severity of in vivo MC toxicity. Mechanistic ex-
planations for these variations in susceptibility are unknown.  Fasted rats 
were more sensitive to MC toxicity (Miura et al. 1991).  The LD50 for 
fasted rats dosed i.p. was half that of fed rats (72 µg/kg and 122 µg/kg, re-
spectively).  Several studies have indicated that male mice are more sensi-
tive than females to the effects of repeated doses of MC (Falconer et al. 
1988).  Age can also influence susceptibility to MC; older male mice were 
more sensitive to oral doses of MC-LR than young male mice (Ito et al. 
1997b).  Strain differences were demonstrated when Ito et al. (2000) found 
that Balb/C mice were more sensitive to MC-LR than ICR mice following 
12 weeks of repeated oral dosing.  It is reasonable to expect that differ-
ences in sensitivity to MCs will also be present in human populations. 
Researchers have also compared MC toxicity resulting from different 
dosing modalities.  Liver damage from ileal loop dosing was similar to that 
observed after intravenous dosing (Stotts et al. 1997a, 1997b; Dahlem et 
al. 1989).  Intracheal administration of MC-LR to male mice was as toxic 
as i.p. doses, with a delay of 60 min (Ito et al. 2001).  Inhalation exposure 
of BALB/C mice to 260–265 mg MC-LR/m3 for 0.5, 1.0, or 2.0 hours/day 
for 7 days resulted in degeneration and necrosis of the respiratory epithe-
lium but no liver damage (Benson et al Toxicon 45: 691-698, 2005).  The 
lack of hepatotoxicity was attributed to the deposited dose (2.5 mg micro-
cystin/kg in the high-dose group) being far below the no observable ad-
verse effect level (NOAEL) of 200 mg/kg/day for induction of hepatotox-
icity. 
Charge 4: Identify and prioritize research needed to improve 
our understanding of human susceptibility factors for adverse 
effects from cyanotoxin exposure. 
The Harmful Algal Research and Response plan (HARRNESS 2005) also 
prioritized studies to investigate integrated toxin effects and mechanisms 
of susceptibility with emphasis on characterizing acute and long term ef-
fects of HAB toxins, defining mechanisms of susceptibility (e.g. identify-
ing special risk populations), and integrating laboratory animal model data 
and wildlife exposure information with human exposures and disease.  We 
concur with these research needs and further delineate research priorities 
below. 
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Near-term Research Priorities 
• Mechanisms as indicated by toxicokinetics/toxicodynamics work 
- P450/GST profile–susceptibility may be determined by polymorph-
ically expressed metabolizing enzymes 
o Focus on links between CYN metabolism by CYP450s and human 
susceptibility due to variations in expression of human CYP 
enzymes 
o MC susceptibility may be similarly affected by variability in GSTs 
Long-term Research Priorities  
• Race, age, sex, and individual health status 
• Nutritional status 
• Epidemiological studies with an emphasis on dose/exposure charac-
terization 
• Identification of special risk populations through integration of 
laboratory animal model data and wildlife exposure information with 
human exposures and disease 
Charge 5: Genetics/OMICS of Cyanobacterial Toxin 
Production 
Identify and prioritize genetic/OMICS research needed to improve 
the prediction of cyanobacterial HABs. 
Research Priority: Characterization of genomes, 
transcriptomes, and proteomes 
Whole genome sequencing of Microcystis, Cylindrospermopsis, Lyngbya, 
and Anabaena and bioinformatic analyses are of high priority and may be 
more cost-effective than attempting to isolate individual genes that in-
fluence the expression of the toxin gene clusters.  Whole genome sequen-
cing produces huge amounts of data in a short time and enables the 
characterization of biosynthetic pathways and the development of tools, 
such as microarrays, needed to describe synthesis regulation.  As sequen-
cing costs are constantly declining this option is becoming more and more 
feasible for most projects.  The Sivonen lab in Helsinki, Finland, is nearing 
352
completion of the whole genome sequencing of a hepatotoxin-producing 
Anabaena, and a microcystin-producing Microcystis genome is nearly fin-
ished at the Pasteur Institute. However, the present capacity and speed of 
sequencing in USA-based institutes is such that more genomes can be done 
relatively quickly and cheaply.  Determining more whole genome se-
quences from these harmful cyanobacteria will allow comparisons be-
tween, for example, toxic and non-toxic genomes of the same species, 
speeding up identification of not only toxin genes but also regulatory genes 
involved in toxin expression. We propose that priority should be given to 
determining the whole genomes of a second Microcystis, toxic and non-
toxic strains of both Cylindrospermopsis and Lyngbya, and two neurotoxic 
Anabaena strains – one saxitoxin producer and one anatoxin-a producer.  
If whole-genome sequencing is not possible, the toxin gene clusters should 
at least be identified, thereby enabling the development of PCR-based 
assays for potential toxin production.  In addition to whole genome 
sequences, global transcriptional and proteomic analyses would reveal 
mRNA transcripts and proteins correlated with the expression of 
cyanobacterial toxins.  This information would advance our understanding 
of how toxin production is regulated by cyanobacteria and in response to 
the ecophysiologic influences of external forces (e.g., light, nutrient 
availability, etc.). 
The complete biosynthetic gene clusters are known for microcystin and 
nodularin. This information has allowed for detailed studies on the regula-
tion of cyanotoxin production and the development of molecular tools for 
detecting particularly harmful species in the environment.  These genes 
can be used as an indicator of potential toxin production, alerting water 
quality managers to the possibility of a toxic bloom.  Reservoirs can be 
monitored by extracting DNA from whole algal communities, and using a 
PCR-based assay to test for the presence of a gene fragment involved in 
coding the microcystin synthetase complex (e.g., Hisbergues et al. 2003).  
Genetic information is also critical for detecting and understanding the 
production of other cyanobacterial toxins. Only a partial gene cluster 
analysis has been derived for cylindrospermopsin synthetase.  Identi-
fication of the complete genetic sequence for cylindrospermopsin syn-
thetase should be given high priority due to the prevalence and distribution 
of this toxin.  Of lower priority are the gene clusters encoding the synthesis 
of the anatoxins, saxitoxins, and other paralytic shellfish poisons found in 
freshwater.  It is proposed that a strain of C. raciborskii AWT205 (cylin-
drospermopsin), Oscillatoria or Anabaena spp. (anatoxin-a and anatoxin-
a(s)), and either C. raciborskii T3 or a strain of A. circinalis (saxitoxin) be 
chosen for genome sequencing.  Contaminating bacteria in co-culture with 
these cyanobacteria should be removed prior to DNA extraction and clon-
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ing.  In addition, genes that interact with the toxin gene clusters remain to 
be fully described in Microcystis, and are completely unknown for the 
other organisms.  The genomic data are needed to apply proteomic and 
transcriptomic analyses. Global transcriptional and proteomic analyses can 
reveal mRNA transcripts and proteins correlated with the expression of 
cyanobacterial toxins.   
If whole genome sequencing is not feasible, an alternative approach is 
to: 
• Use global transcriptional and proteomic analyses to locate mRNA 
transcripts and proteins correlated with the expression of cyanobacterial 
toxins; 
• Use these data to identify the biosynthetic pathways; 
• Mutate the pathways to confirm; 
• Identify biosynthetic genes for expression; 
• Use this information to develop genetic markers for toxin production; 
• Communicate: outreach/education to distribute these tools to local water 
quality agencies. 
Research Priority: Identification, characterization, and 
confirmation of unknown genes for toxin pathways 
As noted above, the major cyanobacterial toxin pathways that have not yet 
been identified or fully characterized are cylindrospermopsin, saxitoxin, 
anatoxin-a, and anatoxin-a(s). The proposal of a putative biosynthetic 
pathway has been a successful approach to identifying toxin gene clusters.   
The first step usually involves feeding experiments with isotope-labeled 
precursors for the identification of metabolic intermediates. Once these in-
termediates have been identified, candidate enzymes can be postulated to 
catalyze these reactions. The next step usually involves searching for genes 
that encode those putative enzymes in the producing organisms, via degen-
erate PCRs targeting of conserved domains in these enzyme families, or by 
screening genomic libraries with labeled probes for putative genes. The 
most suitable target genes encode unique enzymes that are not involved in 
primary metabolic pathways. Because cyanobacterial (and other bacterial) 
toxin genes are organized into clusters, it is usual that the rest of the en-
zymes involved in the biosynthesis are located adjacent to the identified 
candidate gene. Following the identification and sequencing of a candidate 
gene, “genome walking” techniques such as adaptor-mediated and inverse 
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PCR can be implemented in order to sequence regions around the candi-
date gene, thereby revealing whether this candidate gene is part of the en-
tire toxin gene cluster.  
Confirmation of the role of a putative toxin gene cluster in toxin 
production is usually accomplished by creating a mutant strain.  Confir-
mation is attained when deletion of a critical part of the toxin gene cluster 
abolishes toxin production. Mutation methods include gene deletion, 
insertional mutagenesis, and point mutation. Candidate organisms for 
anatoxin-a toxin gene cluster identification and confirmation include 
Anabaena flos-aquae, Oscillatoria sp., or Aphanizomenon sp.  The only 
known producer of anatoxin-a(s) is an Anabaena sp.  Knockout confir-
mation of a saxitoxin putative gene cluster could be conducted in a variety 
of organisms, including Anabaena, Cylindrospermopsis, certain hetero-
trophic bacteria, and several dinoflagellate species. The putative Cylindro-
spermopsin gene cluster should be mutated in Cylindrospermopsis 
raciborskii or Anabaena bergii.  Nodularia spumigena is suitable for 
identification and confirmation of a nodularin synthetase gene. 
Research Priority: Expression of biosynthetic genes 
Cyanobacteria are notoriously difficult to culture in the absence of con-
taminating bacteria, and methods for genetic manipulation have been de-
scribed for only a few species.  Therefore, verification of putative toxin 
biosynthesis genes in cyanobacteria by mutational studies is intrinsically 
difficult. The only cyanobacterial toxin gene cluster that has been charac-
terized by gene disruption and mutant analysis is that for microcystin in 
Microcystis, Anabaena, and Planktothrix. An alternative approach to gene 
disruption and mutant analysis is the cloning, heterologous expression, and 
biochemical characterization of purified recombinant protein. Several 
cyanobacterial toxin gene clusters have been identified by screening ge-
nomic libraries with probes that target candidate biosynthesis genes. Upon 
identification of candidate gene clusters, the sub-cloning and heterologous 
expression of candidate genes has led to the characterization of gene clus-
ters for several cyanobacterial metabolites, such as jamaicamide, lyngbya-
toxin A, and barbamide. Heterologous expression is not limited to individ-
ual genes. Entire gene clusters may also be transferred to metabolically 
engineered strains that are capable of complex secondary metabolite pro-
duction, such as Escherichia coli BAP1. This approach was successfully 
used to express the biosynthesis of the siderophore yersiniabactin and a 
precursor to the antibiotic erythromycin. Once heterologous expression is 
established in a host strain, which is amenable to genetic manipulation, 
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mutant analysis can be performed with relative ease. In addition, such a 
system would be essential for the rational design of metabolic products 
with enhanced pharmacological activities via combinatorial biosynthesis. 
Biosynthetic enzymes in Cylindrospermopsis raciborskii T3 have been 
assayed and there was evidence to indicate differences between the me-
tabolism of STX and the C1+2 toxins and high turnover rates of STX bio-
synthetic enzymes (Pomati et al. 2004). Saxitoxin metabolic pathways 
have been studied through examinations of the purine degradation pathway 
(Pomati et al. 2001). 
Research Priority: Gene probe development for strain 
detection and potential for gene transfer 
The development and validation of gene probes for phylogenetic classifi-
cation and toxin-production potential are needed.  Further research is re-
quired to validate the currently available toxin gene probes for use on a va-
riety of sample matrices such as water and sediment. Gene probes for 
paralytic shellfish poisons and the anatoxins have not been developed.  
Probes are also needed for differentiating cyanobacterial potential to pro-
duce the different congeners of microcystin and the saxitoxin-related 
molecules. The acquisition of toxin gene clusters by non-toxic species and 
the recognition of new toxins is a constant threat. Continued monitoring is 
required, using a combination of genetic, microbiological and toxicologi-
cal approaches.  
Charge 5: Identify and prioritize genetic/OMICS research 
needed to improve the prediction of cyanobacterial HABs. 
Research Priorities 
• Genomes, transcriptomes, and proteomes 
- Near-term Research Priorities 
o High priority: achieving the completed sequence of cylindro-
spermopsin synthetase due to the prevalence and distribution of 
this toxin 
o There is broad consensus regarding the high priority of including 
the toxic freshwater cyanobacteria in future genome sequencing 
projects, particularly Microcystis, Cylindrospermopsis, Lyngbya, 
and Anabaena 
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- Long-term Research Priorities 
o Of lower priority are the gene clusters encoding synthesis of 
anatoxins and saxitoxin and other paralytic shellfish poisons 
found in freshwater 
o Apply proteomic and transcriptomic analyses for the under-
standing of the ecophysiology of cyanotoxin production 
• Identification and characterization of unknown genes for toxin 
pathways  
- Near-term Research Priorities 
o The major cyanobacterial toxin pathways not yet identified or fully 
characterized are cylindrospermopsin, saxitoxin, anatoxins-a, and 
-a(s) 
o Identify metabolic precursors using isotope- or radiolabeled 
feeding experiments 
o Search for genes that encode putative biosynthetic enzymes in the 
producing organisms 
o Sequence candidate genes and regions around the gene 
• Mutation of gene clusters to confirm role in toxin production  
- Near-term Research Priorities 
o A saxitoxin putative gene cluster could be mutated in any of the 
toxin-producing organisms where the toxin gene sequences have 
been found 
o The putative Cylindrospermopsin gene cluster should be mutated 
in Cylindrospermopsis raciborskii or Anabaena bergii 
o The nodularin synthetase gene cluster should be mutated in 
Nodularia spumigena. 
• Expression of biosynthetic genes  
- Longer-term Research Priorities 
o Cloning, heterologous expression, and biochemical charac-
terization of purified recombinant protein 
o Screening genomic libraries with probes that target candidate 
biosynthesis genes 
o Sub-cloning and heterologous expression of candidate genes to 
characterize toxin-coding gene clusters 
o Once heterologous expression is established in a host strain 
amenable to genetic manipulation, mutant analysis can be 
performed  
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• Gene probe development for strain detection and potential for gene 
transfer 
- Near-term Research Priority 
o Further research is required to validate the toxin gene probes 
- Long-term Research Priorities 
o Gene probes directed to both phylogenetic and toxigenic markers 
are also required for the detection of cyanobacteria that produce 
paralytic shellfish poisons and the anatoxins 
o Develop a series of probes for differentiating cyanobacterial 
potential to produce the different congeners of microcystin and 
the saxitoxins 
Charge 6:  Predictive Model Development 
What additional information is needed to develop predictive models 
for the production and fate of cyanotoxins? 
Physical, chemical, genetic, physiological, and ecological information are 
all needed to develop models to predict the production of cyanotoxins.  At 
present, the genetic mechanisms that regulate toxin production are mostly 
uncharacterized, although we do know that toxin production can vary in 
response to ecological factors, including temperature, light availability, nu-
trient availability, grazing, and competition (Yin et al. 1997, Kearns and 
Hunter 2000, Thacker et al. 2005).  Mechanistic understanding of the in-
teractions between these modulating factors and the expression of biosyn-
thetic genes and cofactors in the target organisms is needed.  The capabil-
ity to predict the fate of cyanotoxins once produced is dependent on 
knowledge of toxin transport and reactivity/adsorption with various envi-
ronmental and water treatment matrices. 
Genomic and proteomic analyses would advance our knowledge of the 
cofactors required for toxin expression, including possible promoters of 
toxin synthesis.  These analyses may also reveal how toxins are trans-
ported, stored in the cell, or released to the extracellular environment.  The 
natural roles of many cyanotoxins also remain to be described.  Although 
cyanotoxins are often hypothesized to act as defenses against predation, 
some herbivores preferentially feed on cyanotoxins (Paul et al. 2001, 
Camacho and Thacker 2006).  The growth of sympatric bacteria and algae 
can be inhibited by cyanotoxins, but secretions from these potential com-
petitors can also regulate toxin production (Kearns and Hunter 2000). 
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Research Priority: Characterize environmental, biochemical 
and trophic factors that regulate toxin gene expression 
Previous toxin-regulation studies have yielded disparate results, primarily 
due to a lack of methodological standardization. Different culture tech-
niques (eg. batch cultures, chemostats, turbidistats, etc.) can have a signifi-
cant impact on experimental outcomes, as can the different methods used 
for toxin quantification (eg. toxin versus wet or dry cell weight, cell num-
ber, total protein content, chlorophyll content, optical density, etc.). 
Physiological differences between cyanobacterial strains may also affect 
experimental results and the interpretation of data. Therefore, when inves-
tigating the influence of any given environmental parameter on toxin pro-
duction, the organism’s optimal growth requirements must be taken into 
account before assigning “high/low” values to experimental variables (eg. 
light intensity, nutrient concentration etc.). 
The characterization of natural and engineered non-toxic mutants may 
be the key to understanding why cyanobacteria produce secondary metabo-
lites. By comparing and contrasting mutant and wild-type responses to dif-
ferent growth conditions, it may be possible to pinpoint the physiological 
pathways linked to toxin production. The discovery of complete 
cyanotoxin biosynthesis-gene clusters (eg. anatoxin, saxitoxin, and cylin-
drospermopsin), and the development of genetic manipulation techniques, 
is critical to this area of research. Investigating cyanotoxin production at 
the genetic level, through methods such as RT-PCR and reporter gene 
analysis may prove to be more efficient and cost-effective compared to 
traditional end-product analyses. The positive influence of light on the 
transcription of microcystin biosynthesis genes has been demonstrated. 
Similar methods may also be employed to investigate the effects of tem-
perature, stress, nitrogen and phosphorus types and levels, and trace metals 
in other cyanobacteria following the elucidation of their respective toxin 
biosynthesis-gene clusters. Ultimately, the provision of genome sequences 
for the model toxin-producing strains will allow the global analysis of ge-
netic transcription, including the interaction between, and regulation of, 
both secondary and primary metabolism in these bloom-forming microor-
ganisms. 
Research on the regulation of toxin production in cyanobacteria has 
mainly focused on the transcriptional regulation of toxin genes. However, 
toxin production may also depend on factors such as the availability of co-
factors in the producing cells, as well as the stability and post-translational 
modification of biosynthetic enzymes. One cofactor essential for all poly-
ketide and non-ribosomal peptide producing enzymes is phospho-
pantetheine, which acts as a covalent attachment site for activated acyl- 
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and peptidyl chains. Phosphopantetheine is transferred from coenzyme A 
to a conserved serine residue of acyl- and peptidyl carrier proteins by 
phosphopantetheinyltransferase. So far, little effort has been made to char-
acterize cyanobacterial phosphopantetheinyltransferases involved in toxin 
production. Bacteria have also been shown to affect toxin production by 
algae. Removal of bacteria from saxitoxin-producing dinoflagellate cul-
tures was shown to reduce their toxicity. Similar effects have been ob-
served with domoic acid-producing diatoms. It is believed that trophic in-
teractions between bacteria and algae may be responsible for this effect on 
toxin production.  Research is needed to describe the constituents and in-
teractions in toxin-production pathways. 
Research Priority: Mechanisms of toxin transport 
Previous toxin-regulation studies have observed an increase in extracellu-
lar microcystins under certain growth conditions. The active export of the 
toxin, by the ABC transporter McyH, has been hypothesized, but not yet 
proven. The overexpression, purification and reconstitution of cyanotoxin-
associated transporters such as McyH into membrane vesicles may enable 
us to demonstrate transport in vitro with radiolabeled toxins. While bioin-
formatic and mutational data suggest that McyH is responsible for micro-
cystin transport, it is still unclear whether this enzyme transports the toxin 
to the extracellular environment or to the thylakoid membranes. Intracellu-
lar localization of McyH and other cyanotoxin-associated ABC transport-
ers by in situ methods may shed light on this area of research. Techniques 
for observing the intracellular trafficking of all cyanotoxins, including de-
velopment of specific toxin and transporter antibodies, as well as cyano-
bacterial imaging methods, are required. 
Research Priority:  Determine the ecological/physiological 
role(s) of cyanotoxins  
Without question, toxins provide some functional benefit to cyano-
bacterial. This statement follows from the observation that toxins, or struc-
turally similar compounds, are produced by most of the surveyed cyano-
bacterial lineages. Equally compelling is the inference that cyanotoxins 
may play a critical role in cyanobacterial populations or trophic interac-
tions. What remains in question is what, precisely, is that role. Some 
cyanobacterial toxins may serve as physiological tools to increase survival 
in hostile environmental conditions, or to enable the colonization of a 
novel habitat. Others may play a defensive role and act to prohibit the in-
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vasion of other strains or species into an occupied niche, limit the advance 
of neighboring cells, or discourage grazers and predators. An additional 
role could be as signaling molecules, mediating cell-cell communication or 
quorum sensing. It is likely that whatever roles cyanotoxins play, these 
roles change in accordance with the flux of biotic and abiotic components 
of the environment. 
Characterization of the beneficial roles of toxins in cyanobacterial cells 
or populations requires delineation of the molecular effects of the specific 
toxins on the physiology and fitness of the producing microorganisms, 
populations, and ecology of the various species. Knowledge of the genetic 
basis for cyanotoxin biosynthesis and regulation will enable a functional 
genomic approach to the study toxin roles. DNA or protein chips, and 
gene/protein expression profiling tools in general, could offer valuable 
data on co-transcription of toxic genes/proteins with other genetic net-
works in experimental sets chosen to mimic changing environmental con-
ditions. Such conditions could also include the stress induced by other 
competing microorganisms, predators or grazers. A functional association 
of toxin biosynthetic genes with cellular and metabolic responses to spe-
cific stressors will undoubtedly help in elucidating the toxins molecular 
role. Protein expression studies could provide further information regard-
ing the activation of metabolic pathways (e.g., phosphorylation of signal-
ing proteins) in association with toxin production, and the functional roles 
of toxins in activities such as cyanobacterial quorum sensing and percep-
tion. 
Mutagenesis and gene disruption techniques could confirm functional 
genomic data, and be crucial for investigating the role of toxins in the 
physiology of producing cyanobacteria. The function of any given 
cyanotoxin, as well as the conditions that induce variation in both toxin 
production levels and toxin structure, could be elucidated by studying 
toxin gene mutants. Broad physiological parameters (e.g., growth) are 
needed to understand how mutations in toxic genes affect single-cell phe-
notypes or the structure of an entire population.  Both predators and bacte-
riophage viruses have been shown to play important roles in the ecology 
and dynamics of cyanobacterial species. The role of protozoan predation 
on the natural selection of toxin-producing cyanobacterial species is not 
clear. To date, possible connections between bacteriophage and the pro-
duction of cyanobacterial toxins have not been explored. These data are 
needed to produce theoretical and empirical models of the conditions that 
favor the proliferation of toxin-producing cyanobacteria. 
A clearer understanding of interactions between cyanobacterial physiol-
ogy and physical, chemical, and biological factors such as light availabil-
ity, nutrient availability, grazers, and competitors is needed to produce 
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models that successfully predict the production and fate of cyanotoxins.  
Knowledge of mechanisms regulating the expression of biosynthetic genes 
and cofactors in the target organisms is needed to characterize these inter-
actions.  Although these studies can be conducted using global transcrip-
tional and proteomic assays, greater sensitivity and power would be gained 
if the biosynthetic pathways were known a priori.  Integrating these studies 
with knowledge of the entire genome sequence would provide additional 
predictive power. 
Charge 6: What additional information is needed to develop 
predictive models for the production and fate of cyanotoxins? 
Genetic, physiological, and ecological information are all needed to de-
velop a model to predict the production of cyanotoxins. 
Research Priorities 
• Environmental effects on toxin production 
- Near-term Research Priority 
o Methodological standardization for toxin regulation studies - take 
into account organism’s optimal growth requirements before 
assigning “high/low” values to experimental variables (eg., light 
intensity, nutrient concentration etc.) 
- Long-term Research Priorities 
o Characterize natural and engineered non-toxic mutants to 
understand why cyanobacteria produce secondary metabolites 
o Compare and contrast mutant and wild-type responses to different 
growth conditions to pinpoint physiological pathways linked to 
toxin production 
o Investigate cyanotoxin production at the genetic level, through 
methods such as RT-PCR and reporter gene analysis to examine 
the effects of light, temperature, stress, nitrogen source and level, 
and trace metals in cyanobacteria following the elucidation of 
their respective toxin biosynthesis-gene clusters 
• Other factors affecting toxin production 
- Near-term Research Priorities 
o Continue characterization of the transcriptional regulation of toxin 
genes 
o Genomic and proteomic analyses to describe the cofactors 
required for toxin expression, including possible promoters of 
toxin synthesis 
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o Describe the dependence of toxin production on factors such as the 
availability of cofactors in the producing cells, as well as the 
stability and post-translational modification of biosynthetic en-
zymes 
o Characterize cyanobacterial phosphopantetheinyltransferases in-
volved in toxin production 
- Long-term Research Priority 
o Determine effects of trophic interactions between bacteria, 
bacteriophage viruses, and algae on toxin production 
• Physiology 
- Long-term Research Priorities 
o Describe the mechanisms of interactions with light availability, 
nutrient availability, grazers, and competitors by examining the 
expression of biosynthetic genes and cofactors in the target 
organisms 
o Integration of these studies with knowledge of the entire genome 
sequence would provide additional predictive power. 
• Toxin transport/fate 
- Near-term Research Priorities 
o Describe toxin adsorption in environmental and water treatment 
martrices 
o Use overexpression, purification, and reconstitution of cyanotoxin-
associated transporters such as McyH into membrane vesicles to 
enable us to demonstrate transport in vitro with radiolabeled toxin 
o Intracellular localization of McyH and other cyanotoxin-associated 
ABC transporters by in situ methods 
- Long-term Research Priorities 
o Development of techniques for observing the intracellular traffic-
king of all cyanotoxins, including development of specific toxin 
and transporter antibodies, as well as cyanobacterial imaging 
methods, are required 
• Role of toxins in ecology/physiology of toxic cyanobacteria 
- Long-term Research Priorities 
o Characterize the roles of cyanobacterial toxins within the pro-
ducing organisms by describing the molecular function of the 
specific toxin on the physiology and fitness of the producing 
microorganism, and on its influence on population structure and 
ecology of the given species 
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o Use functional genomic investigations to describe associations of 
toxin biosynthetic genes with cellular and metabolic responses to 
specific stressors 
o Describe the roles of toxins in activities such as cyanobacterial 
quorum sensing and perception using protein expression studies to 
provide crucial information regarding the activation of metabolic 
pathways (e.g., phosphorylation of signaling proteins) associated 
with toxin production  
o Confirm functional genomic data using mutagenesis and gene 
disruption techniques to elucidate the roles of toxins in the 
physiology of producing cyanobacteria 
o Determine the role of protozoan predation in the natural selection 
of toxin-producing cyanobacterial species 
Charge 7: Intentional/Accidental Release 
Identify and prioritize research needed to reduce risks from an inten-
tional or accidental release of cyanotoxins. 
Several cyanotoxins have the potential to cause significant harm to human 
populations if intentionally or accidentally released through an environ-
mental contamination event.  The National Homeland Security Research 
Center (NHSRC) must now address critical issues that other programs may 
not have had to consider previously.  Recent security interests have placed 
new and more pressing demands on the assessment of risks from exposure 
to biological agents through deliberate contamination.  Distribution and 
possession of saxitoxin is already governed by Schedule 1 of the Chemical 
Weapons Convention as well as the Select Agent Rule.  Therefore, saxi-
toxin and other cyanotoxins need to be evaluated for their risks to human 
health as well as their potential for intentional contamination.  The high 
toxicity of several cyanotoxins at low concentrations warrants a thorough 
risk assessment of the most hazardous cyanotoxins.  Research on exposure 
pathways and modes of delivery is needed to identify the cyanotoxins and 
the environmental conditions that present the greatest health risks. 
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Research Priority: Scientifically-sound risk assessments are 
needed to identify toxins with potential for use as terrorist 
agents 
Data are needed to support scientifically-sound assessments of human-
health risks from exposure to many cyanotoxins, particularly the risks 
posed by mixtures of cyanotoxins.  Health risks should be based not only 
on exposure concentration, but also on route-of-exposure.  Cyanotoxicity 
studies have focused primarily on toxicity resulting from oral ingestion. 
Much less is known about toxicity resulting from dermal and inhalational 
exposures.  Many critical issues concerning mixtures and routes-of-
exposure should be addressed, including bioavailability, interactions be-
tween toxins, direct modes of action, and indirect effects through immune 
system activation.  
The risk assessment process involves parallel assessments of the hazard 
and exposure.  However, additional parameters such as feasibility and vul-
nerability are required to assess risks from malevolent releases of biohaz-
ardous agents or materials.  In the event of a release of a biological agent, 
the United States Environmental Protection Agency (USEPA) would re-
spond in accordance with the Homeland Security Presidential Directives 5, 
7, 9 and 10.  The USEPA has mandated roles in decontamination, water in-
frastructure protection, and risk assessment.  The risk associated with a de-
liberate exposure situation is one of the drivers for decisions regarding 
evacuation, decontamination, and eventual re-entry into a site or re-use of 
a water system.  A contaminating event with cyanobacteria and/or cyano-
toxins would require several layers of investigation.  Contamination with 
saxitoxin (and potentially other cyanotoxins) would require distinguishing 
between a natural or intentional contaminating event. Risk-based decisions 
would need to be made concerning decontamination. 
Several existing studies describing the chemical nature and charac-
teristics of the saxitoxins are informative for risk assessments. Degradation 
and biotransformation of the saxitoxins have been investigated in vitro 
(e.g. Sullivan et al. 1983; Laycock et al. 1995), and in response to tempera-
ture (e.g. Lawrence et al. 1994), pH (e.g. Hall and Reichardt 1984; Gago-
Martinez et al. 2001), combinations of temperature and pH (e.g. Ghazaros-
sian et al. 1976, Indrasena and Gill 1999, Indrasena and Gill 2000). Saxi-
toxins in drinking water have been degraded using chlorine, and exposure 
to the treated solution did not result in increased cancer (Senogles-Derham 
et al. 2003). Removal of saxitoxins from drinking water using granular ac-
tivated carbon, ozone, and hydrogen peroxide also has been examined (Orr 
et al. 2004).  
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The need to control access to potential terrorist agents such as saxitoxins 
is evident. However, the classification of toxins as potential terrorist agents 
causes restrictions to be placed on their distribution, thereby limiting re-
search efforts. Efficient means for supplying sufficient quantities of cyano-
bacteria and cyanotoxins to researchers are needed because much of the 
data on which to base sound risk assessments are unavailable.  Distribution 
efficiency can by increased by ensuring that requested quantities closely 
correspond to research (and commercial) needs.  For example, laboratories 
developing reference standard materials may require larger quantities than 
research labs conducting physical or biochemical analyses. The regulations 
regarding handling should be clear and manageable to promote compli-
ance.  The most current information regarding registration and handling of 
select agents can be accessed via internet websites (http://www.opcw.org 
and http://www.selectagents.gov ).   
Early detection of cyanobacterial HABs and the presence of cyanotoxins 
in the environment, whether due to natural or intentional causes, is critical 
for public health protection.  Improved techniques are needed to detect and 
identify HAB organisms, and to determine the potential for toxin produc-
tion.  Techniques also are needed to identify and quantify cyanotoxins, 
alone and in mixtures, and in various matrices.  Molecular, genetic, and 
biochemical techniques hold promise for the development of techniques 
that are field-ready, rapid, reliable, and inexpensive.  Homeland Security 
will benefit from methods that enable the presence of HABs and cyanotox-
ins in the environment to be classified as intentional or natural events. 
Additional issues of importance to Homeland Security include the po-
tential for bioaccumulation of cyanotoxins in plants, the aerosolization of 
cyanotoxins, and the induction of HABs in urban drinking water sources. 
Research has indicated the potential for cyanotoxin accumulation in agri-
cultural crops when surface water contaminated with cyanobacteria is used 
for spray irrigation.  Colonies and single cells of Microcystis aeruginosa 
and microcystin were retained by salad lettuce after spray irrigation with 
water containing microcystin-producing cyanobacteria (Codd et al. 1999). 
The uptake of toxins (pure as well as from cyanobacterial crude extracts) 
in different crop plants was also shown by Pflugmacher et al. (2006), 
Peuthert et al (2007 in press) and Järvenpää et al. (2007).  Additional re-
search is needed to characterize the risk posed by contaminated spray irri-
gation.  Research is also needed to characterize the potential for aerosoli-
zation of cyanotoxins, the stability of cyanotoxins in various environ-
mental matrices, the bioavailability of cyanotoxins bound to various 
matrices, the bioavailability of inhaled cyanotoxins, and cyanotoxin der-
mal transfer coefficients.  Research is needed to assess the potential for in-
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tentional induction of cyanobacterial HABs in surface waters, and to de-
velop emergency risk management procedures. 
Charge 7: Identify and prioritize research needed to reduce 
risks from an intentional or accidental release of cyanotoxins. 
Near-term Research Priorities 
• Scientifically-sound risk assessments are needed to identify toxins with 
potential for use as terrorist agents  
- Use appropriate dose-response data to define “significant quantities” 
below which there is no threat associated with the shipment and 
possession of cyanotoxins for research purposes 
• Detection methods 
- Advances in monitoring for cyanobacteria and cyanotoxins are 
needed for early detection to prevent exposure 
- Biochemical and molecular techniques that yield detection signatures 
of cyanotoxins and cyanobacterial blooms are needed to discriminate 
natural versus unnatural contamination 
Long-term Research Priorities 
• Stability and degradation studies 
- Characterize cyanotoxin stability in various matrices, including food 
crops after contaminated spray irrigation 
- Characterize the physical and chemical parameters that enhance 
bioaffinity of toxin to various substrates  
- Characterize bioaccumulation and other natural concentration 
mechanisms 
• Exposures other than oral 
- Describe changes in cyanotoxin modes of action based on exposure 
pathway and the presence of other cyanotoxins 
- Describe cyanotoxin aerosolization potential, stability, and 
bioavailability  
- Characterize the health risk of cyanotoxin inhalation, alone and in 
mixtures 
- Determine dermal transfer coefficients for cyanotoxins  
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Summary of Near-Term Research Needs for Highest 
Priority Cyanotoxins 
Table 3 presents a summary of priority near-term research needs for the 
most prevalent cyanobacterial toxins.  “Needs” boxes marked with a check 
(?) indicate that little or no data is currently available for a given area of 
need.  “Exist” boxes left blank indicate that the Workgroup was not aware 
of existing data or research efforts that address the specified area. 
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